Podcasts about CVS

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Miko Branch. Here is a clear, structured summary of the Miko Branch interview with Rushion McDonald, along with its purpose, key takeaways, and notable quotes, drawn directly from the transcript you provided.All information cites the uploaded file. SUMMARY OF THE INTERVIEW In this Money Making Conversations Masterclass episode, Rushion McDonald interviews Miko Branch, co‑founder and CEO of Miss Jessie’s, a pioneering hair‑care brand serving people with textured, curly, kinky, and wavy hair. Miko recounts how she and her late sister, Titi Branch, built Miss Jessie’s from their kitchen table in their Brooklyn brownstone, developing products designed to genuinely work for people with textured hair. She highlights the brand’s deeply personal roots—named after their grandmother Jessie Mae Branch, the first “CEO” they ever observed in action. Throughout the interview, Miko explains how Miss Jessie’s expanded from grassroots marketing, word‑of‑mouth, and early internet chat rooms to becoming a national brand found in Walgreens, CVS, Target, and more. She stresses the brand’s emphasis on education, authenticity, and providing solutions for all textured hair types. Miko also discusses signature product lines (Curly Pudding, Pillow Soft Curls, Daily Soft Curls, sulfate‑free shampoo) and how Miss Jessie’s became a leader in the natural hair movement—well before it became a mainstream trend. PURPOSE OF THE INTERVIEW 1. To showcase Miss Jessie’s origin story and entrepreneurial journey McDonald highlights how Miko built a multimillion‑dollar brand from her kitchen table. 2. To inspire current and aspiring entrepreneurs Miko demonstrates how authentic problem‑solving creates brand loyalty and long-term success. 3. To educate listeners about textured hair and the natural hair care industry The interview reinforces that natural hair is not a trend—it's an identity and lifestyle. 4. To highlight the importance of cultural heritage and family influence Miko shares how her grandmother, her sister, and her Brooklyn salon shaped Miss Jessie’s values and innovation. KEY TAKEAWAYS 1. Miss Jessie’s was built on authenticity and real consumer needs The brand emerged from real hairstyling challenges Miko and Titi solved for themselves and their salon clients.. 2. Education is central to the brand’s success Miss Jessie’s teaches customers how to understand and care for their curl types—wavy, curly, kinky, multicultural, or transitioning.McDonald says the site offers more information than any hair‑care brand he has interviewed. 3. Family legacy guides the company Their grandmother Jessie Mae’s leadership, work ethic, and kitchen‑table lessons inspired their business approach. 4. The natural hair movement is here to stay People increasingly embrace their God‑given texture; straightening is no longer the dominant norm. 5. Social media amplified—did not create—their success Word‑of‑mouth began long before social media; platforms today simply extend their reach. 6. Miss Jessie’s serves everyone with texture—not just Black women Men, boys, Latinas, mixed‑race individuals—anyone with curls or waves—can find a solution. 7. Product innovation drove their growth Curly Pudding, Pillow Soft Curls, Daily Soft Curls, and sulfate‑free shampoos transformed textured hair care. 8. Their Brooklyn salon doubled as R&D It allowed the sisters to test products directly on customers and ensure real‑world performance. NOTABLE QUOTES (from transcript) On the company’s beginnings “We started our business in our brownstone right at our kitchen table.” “Curly Pudding was the groundbreaker—the game changer.” On the brand’s philosophy “The bottom line is being able to create products that are helpful.” “Information and communication is key to success.” On inclusivity “Anyone who has texture… we have something for you.” On natural hair “Natural hair, curly hair is preferred… it’s how people want to express themselves.” “Natural hair is not a trend—it’s here to stay.” On social media and growth “We were going viral before ‘going viral’ was a word.”. On legacy “Our grandmother Jessie was the first female CEO we’d ever seen.”. #SHMS #STRAW #BESTSee omnystudio.com/listener for privacy information.

Listen and subscribe to Money Making Conversations on iHeartRadio, Apple Podcasts, Spotify, www.moneymakingconversations.com/subscribe/ or wherever you listen to podcasts. New Money Making Conversations episodes drop daily. I want to alert you, so you don’t miss out on expert analysis and insider perspectives from my guests who provide tips that can help you uplift the community, improve your financial planning, motivation, or advice on how to be a successful entrepreneur. Keep winning! Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Miko Branch. Here is a clear, structured summary of the Miko Branch interview with Rushion McDonald, along with its purpose, key takeaways, and notable quotes, drawn directly from the transcript you provided.All information cites the uploaded file. SUMMARY OF THE INTERVIEW In this Money Making Conversations Masterclass episode, Rushion McDonald interviews Miko Branch, co‑founder and CEO of Miss Jessie’s, a pioneering hair‑care brand serving people with textured, curly, kinky, and wavy hair. Miko recounts how she and her late sister, Titi Branch, built Miss Jessie’s from their kitchen table in their Brooklyn brownstone, developing products designed to genuinely work for people with textured hair. She highlights the brand’s deeply personal roots—named after their grandmother Jessie Mae Branch, the first “CEO” they ever observed in action. Throughout the interview, Miko explains how Miss Jessie’s expanded from grassroots marketing, word‑of‑mouth, and early internet chat rooms to becoming a national brand found in Walgreens, CVS, Target, and more. She stresses the brand’s emphasis on education, authenticity, and providing solutions for all textured hair types. Miko also discusses signature product lines (Curly Pudding, Pillow Soft Curls, Daily Soft Curls, sulfate‑free shampoo) and how Miss Jessie’s became a leader in the natural hair movement—well before it became a mainstream trend. PURPOSE OF THE INTERVIEW 1. To showcase Miss Jessie’s origin story and entrepreneurial journey McDonald highlights how Miko built a multimillion‑dollar brand from her kitchen table. 2. To inspire current and aspiring entrepreneurs Miko demonstrates how authentic problem‑solving creates brand loyalty and long-term success. 3. To educate listeners about textured hair and the natural hair care industry The interview reinforces that natural hair is not a trend—it's an identity and lifestyle. 4. To highlight the importance of cultural heritage and family influence Miko shares how her grandmother, her sister, and her Brooklyn salon shaped Miss Jessie’s values and innovation. KEY TAKEAWAYS 1. Miss Jessie’s was built on authenticity and real consumer needs The brand emerged from real hairstyling challenges Miko and Titi solved for themselves and their salon clients.. 2. Education is central to the brand’s success Miss Jessie’s teaches customers how to understand and care for their curl types—wavy, curly, kinky, multicultural, or transitioning.McDonald says the site offers more information than any hair‑care brand he has interviewed. 3. Family legacy guides the company Their grandmother Jessie Mae’s leadership, work ethic, and kitchen‑table lessons inspired their business approach. 4. The natural hair movement is here to stay People increasingly embrace their God‑given texture; straightening is no longer the dominant norm. 5. Social media amplified—did not create—their success Word‑of‑mouth began long before social media; platforms today simply extend their reach. 6. Miss Jessie’s serves everyone with texture—not just Black women Men, boys, Latinas, mixed‑race individuals—anyone with curls or waves—can find a solution. 7. Product innovation drove their growth Curly Pudding, Pillow Soft Curls, Daily Soft Curls, and sulfate‑free shampoos transformed textured hair care. 8. Their Brooklyn salon doubled as R&D It allowed the sisters to test products directly on customers and ensure real‑world performance. NOTABLE QUOTES (from transcript) On the company’s beginnings “We started our business in our brownstone right at our kitchen table.” “Curly Pudding was the groundbreaker—the game changer.” On the brand’s philosophy “The bottom line is being able to create products that are helpful.” “Information and communication is key to success.” On inclusivity “Anyone who has texture… we have something for you.” On natural hair “Natural hair, curly hair is preferred… it’s how people want to express themselves.” “Natural hair is not a trend—it’s here to stay.” On social media and growth “We were going viral before ‘going viral’ was a word.”. On legacy “Our grandmother Jessie was the first female CEO we’d ever seen.”. #SHMS #STRAW #BESTSteve Harvey Morning Show Online: http://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Championship winners and cars with multiple victories on their CVs usually grab the limelight when it comes to the greatest cars in Formula 1 history. But there have been some fantastic machines that have narrowly missed out on ultimate glory.  We reckon they deserve recognition, too. So, in the latest of Autosport's Top 10s, leading F1 journalist Maurice Hamilton joins host Kevin Turner to debate and discuss the 10 best F1 cars that never took a title. We've excluded the Lotus 78 because it played a part in Lotus's title double in 1978, prior to the arrival of the 79 (much more so than the 312B3-74 did in 1975), as well as the 1991 Williams FW14 due to its similarity to the gizmo-laden B version that dominated in 1992. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Corner office churn is up as demands multiply. Heidrick & Struggles' CEO explains what CVs leave out and why flexibility and organizational fit matter more as AI and global volatility undercut the predictive power of past performance. Also, AI-enhanced recruiting and lifelong learning.

From societal pressure to financial sacrifice to the brutal truth about why marriage timelines and designer lifestyles are destroying young people's futures - and why the pressure to marry at 28 as a woman or settle down as a man without having your life figured out will send you into depression for the rest of your life watching your classmates buy cars and houses while you struggle, the Instagram illusion where people see someone wearing a beautiful dress and think they bought it when the truth is designers made it and gave it to them for free, the 28-year-old man taking out loans to pay for a wedding he'll spend two years paying off because he allowed societal pressure to control his decisions instead of waiting until he was ready, and why the brutal reality is this: if you go into a relationship, settle down, have another human being to take care of when you're not ready - you will be depressed every day watching your friend Derek who was your classmate doing his podcasts, practicing his pharmacy, able to buy his car, able to buy a house, and you are wondering what's happening to me, while the real question becomes: why are you making your life's clock somebody else's clock when you don't know what they're doing with their money or what other responsibilities they have, because the pressure we felt 25 years ago should not be felt today and the children of today should not go through what we went through with the "at this age you must marry, at this age you must have your car" mentality that puts people in boxes and limits their potential. In this raw episode of Konnected Minds, host Derrick Abaitey sits down with Nana Aba Anamoah - a powerhouse media personality who dismantles the dangerous "follow society's timeline or you're a failure" mentality that pushes people into marriages, debt, and decisions they're not ready for, revealing the exact moment when the girl wearing that dress on Instagram didn't actually buy it because designers made it and gave it to her so don't go looking for money to buy what you see someone else wearing. This isn't motivational life advice from Instagram influencers - it's a systematic breakdown of why the pressure to marry at 28 as a woman or settle down as a man without having your life figured out will send you into depression watching your classmates succeed while you struggle, why people see someone on social media wearing a beautiful dress and think they bought it when designers gave it to them for free so don't go looking for money to buy what you see others wearing, why making your life's clock somebody else's clock is unfair because you don't know what they're doing with their money or what responsibilities they have, why allowing yourself to be put in a box limits your potential and lets people control your narrative, why showing up to a 9 a.m. meeting at 9:15 and waiting until 9:30 is the maximum even if you need a favor because sitting for hours while someone thinks they're big is disrespectful and you will walk out, why being consistently late is disrespectful to other people especially for important meetings, why two people with the best CVs showed up at 10 a.m. for an 8 a.m. interview and didn't get interviewed because if you don't take the interview seriously you won't take the work seriously, why you must have self-respect and standards or you're not heading anywhere, why your character must count for something because people watch and the days when God was just giving out blessings are over - now you have to work for it, why friends were buying new cars every year but the sacrifice was made to pay expensive international school fees and thousands of dollars in US university tuition instead, why wanting to give your child the best education means not buying designer bags that cost 4,000 pounds and not doing certain things for yourself, why making a pact with your son saying "whatever you need I will provide, focus on the books, I'll buy the sneakers and shirts you want, just ace your grades" is the commitment that requires sacrifice, and why if you have a child and want to give them the best education but you're not wealthy like other wealthy people - don't be dreaming of buying designer bags while sitting there unable to pay school fees, making sacrifice, self-respect, and refusing to let society's timeline control your decisions the foundation of building a life where your children get the best opportunities and you don't spend the rest of your days depressed watching others succeed while you struggle under the weight of choices you made to impress people who don't matter. Guest: Nana Aba Anamoah Host: Derrick Abaitey

In this episode of Time for a Reset: Insights from Global Brand Marketers, brought to you by Overline, host Nick King speaks with Pardeep Duggal, Global Marketing Director at Bupa Global, about why marketing must sit at the heart of business transformation, not on its sidelines. Drawing on decades of cross-industry experience, Pardeep shares practical frameworks for earning boardroom credibility, building high-performing teams, and embedding marketing into the core business strategy. From leading with data before creativity to adopting AI through real-world use cases, she outlines how modern marketing leaders can balance rigour with bold thinking. It's a candid, opportunity-focused conversation for CMOs ready to shape strategy, not simply defend spend.Topics Covered: How to reframe marketing's role from communications-only to business transformation by positioning marketing as integral to customer strategy, digital ubiquity, and business outcomes, not as a separate function. The three non-negotiable qualities that define high-performing marketing leaders. Intellectual capability to understand business dynamics, relentless work ethic, and learning agility trump tenure or pedigree.  The "Swoosh" methodology for delivering marketing transformation. Start by fixing operational basics and earning credibility, then paint a three-year vision of progressive change.Why credibility precedes creativity in the boardroom. Lead with a data-driven understanding of business models, revenue drivers, and digital impact before deploying your creative superpower. Numbers open doors; creativity changes minds.The winning team composition is a mix of industry veterans with fresh talent from other sectors. Pair people who understand organizational unwritten rules with outsiders who bring new perspectives. How to connect with the C-suite through emotional immersion, not just dashboards. Use theatrical, real-world experiences, hotel room customer simulations, unfiltered customer sessions, and live store visits to make customer insights visceral and memorable for executives.Pardeep Duggal is the Global Marketing and Digital Director at Bupa Global. She brings three decades of experience transforming customer experiences across heavily regulated industries, including banking, energy, insurance, and healthcare. Known for embedding marketing into enterprise-wide business transformation strategies, she has built high-performing teams at leading organizations, including E.ON, CVS, Santander, and Barclaycard. If you enjoyed this episode, be sure to subscribe, rate, and review on Apple Podcasts, Spotify, and YouTube. Instructions on how to do this are available here.Support the show

The jobseekers who are hiding their ages on CVs

(00:00:00) Opening (00:01:19) A Piece of My Mind (00:06:32) Pancho Guero My Insane FL Nephew (00:25:32) Woman Stranded In A Walmart Parking Lot After Buying 85” TV That Won't Fit In Her Ford Bronco (00:35:22) ROAD RAGE!!...Toothless Florida Nutjob With a Gun (00:39:34) MI Woman Gets Shamed at CVS for "Son's" Unusual Name (00:44:49) Raising Cane's Sues Boston Landlord Over Eviction Threat For “Chicken Finger Odor” (00:49:40) Maryland Paramedic Charged With PEEING On Supervisor's Desk & In Pot Of Chili At Work (00:54:05) Llamas Catch Thief by Surrounding Him in a Field Until Cops Arrive (00:59:15) FridaBaby Faces Backlash Over Sexual Innuendo In Baby Product Marketing (01:10:43) Ask Pancho (01:24:00) Insane Game Show (01:37:48) Coming Next Episode (01:42:04) Closing If there ever was a poster boy for the Florida Man, we have found him and he qualifies for the job perfectly. If there ever was a golden opportunity for an opportunistic busybody to stick their nose into another person's business, my Insane FL Nephew, "Pancho Guero" found her name-shaming a woman checking out at a CVS register. And if there ever was a better way to capture a thief on the run, a herd of 8 therapy llamas fulfilled their civic duty by surrounding the perp until the cops arrived. In this Weekend Episode...[A Piece of My Mind…] Gen Z Woman Embarrassed By Her Generation's ‘Weird, Stunted Social Skills'Woman Stranded In A Walmart Parking Lot After Buying 85” TV That Won't Fit In Her Ford Bronco—And Walmart Refuses Her ReturnROAD RAGE!!...Toothless Florida Nutjob With a GunMI Woman Gets Shamed at CVS for "Son's" Unusual NameRaising Cane's Sues Boston Landlord Over Eviction Threat For “Chicken Finger Odor”Maryland Paramedic Charged With PEEING On Supervisor's Desk and In Pot Of Chili At WorkLlamas Catch Thief by Surrounding Him in a Field Until Cops ArriveFridaBaby Faces Backlash Over Sexual Innuendo In Baby Product Marketing"Pancho" gives his sage wisdom by answering a couple of questions posed to him that deal with knowing about the "flirty" texts that was seen by a woman on the phone screen of her roommate's boyfriend and how it should be dealt with...and is it okay for a girl to "Friend" a guy that she's fallen head over heels in love with, so she can "check up on him". No red flags there! Match your skills against Pancho and play along in this week's Insane Game Show and see if you can score better!Become a supporter of this podcast: https://www.spreaker.com/podcast/insane-erik-lane-s-stupid-world--6486112/support.Real-time updates and story links are found on the TELEGRAM Channel at: https://t.me/InsaneErikLane  (Theme song courtesy of Randy Stonehill, ”It's A Great Big Stupid World”. Copyright ©1992 Stonehillian Music/Word Music/Twitchin' Vibes Music/ASCAP) Order your copy on the Wonderama CD from Amazon!This episode includes AI-generated content.

How AI Weight Loss Coaches Complement Clinical Care Ro Huntriss, Chief Nutrition Officer for Simple Life, shares how their AI weight loss coach complements clinical care, what they've learned about driving personal health behaviors, and why they continue to see success across every age group, gender, and BMI class.  All that, plus the Flava of the Week about CVS' intention to launch a new consumer engagement app. How do they describe the platform they're building and its benefits, and does this signal a renewed interest in consumer engagement as a top priority?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

First up, a major change at the top for Employ Inc.—the powerhouse behind JazzHR, Lever, and Jobvite. The company has officially appointed Jerry Jao as its new CEO. Jao is a serial entrepreneur who founded the AI-powered marketing platform Retention Science. What's interesting here is that Jao isn't just a tech exec; he was actually a Lever customer for six years. He's stepping in with a "founder's mindset" to lead Employ through the GenAI era. His message? Hiring must remain "people-first," but the technology needs to move faster. Watch for Employ to lean even harder into AI innovation to help recruiters make more confident decisions without losing that human connection. https://hrtechfeed.com/employ-inc-appoints-new-ceo/ Next, let's talk about speed. hackajob just announced that its AI recruiting agent, Archer, has surpassed $1 million in Annual Recurring Revenue (ARR) in just 90 days. To put that in perspective, the "pre-AI" gold standard was hitting that million-dollar mark in a year—Archer did it in one quarter. Why is it winning? Because it's tackling the "crisis of trust" in hiring. Archer qualifies candidates before they even hit the ATS, verifying identity and fit to cut through the noise of AI-generated CVs. It's already boasting a 20-to-1 candidate-to-hire ratio—which is 15 times better than the industry average. Originally focused on tech, Archer is now expanding to support all knowledge-worker roles, from finance to operations. https://hrtechfeed.com/hackajob-announces-its-ai-recruiting-agent-has-surpassed-1-million-in-arr/ Moving over to the freelance world, we're seeing a massive pivot at Fiverr. In their 2025 year-end report, they revealed a "quality over quantity" strategy. While they actually lost 14% of their active buyers, the ones who stayed are spending more—average spend per buyer is up 13% to over $340. Fiverr is shifting away from the "five-dollar gig" and moving toward high-end, professional business outsourcing. They're calling 2026 a "reset year" as they re-architect the platform to be AI-native. Along with this shift, they've promoted long-time CFO Ofer Katz to President to focus on strategy and acquisitions. Meanwhile, Upwork is signaling confidence in its own value, announcing a $300 million share repurchase program. This brings their total authorizations to $600 million since late 2023. Both platforms are clearly positioning themselves as high-value enterprise partners rather than just job boards for quick tasks. https://hrtechfeed.com/fiverr-shifts-focus-to-high-end-work-as-ai-transforms-the-gig-economy-2025-results-and-2026-outlook/ https://hrtechfeed.com/upwork-announces-300-million-share-repurchase-program/ Finally, we close with the latest Appcast 2026 Recruitment Marketing Benchmark Report. The big takeaway? We are officially in the "Great Stay." It's a "low-hire, low-fire" environment. People aren't quitting, and the wage premium for job-hoppers has evaporated—it's now nearly the same as staying put. But don't let the slow movement fool you; recruiting isn't getting cheaper. The median cost-per-hire has risen to $1,053. There's a sharp divide between "sitting down" roles (like tech) where pools are crowded, and "standing up" roles (like healthcare) where costs-per-application are as high as $35. If you want to win in 2026, the data says: keep your applications under 5 minutes, disclose the salary, and post on Mondays. Averag cost per click is now around 92 cents by the way… https://recruitingheadlines.com/2026-recruitment-marketing-navigating-the-great-stay/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Work it Like a Mum Podcast, we're sharing the third session from Smash 26, our two-day virtual event designed to help women start the year with confidence, clarity and momentum in their careers.Hosted by recruitment expert Elizabeth Willits, Founder of Investing Women, who shares nearly two decades of insider hiring experience. Having worked at Hays and Deloitte, Liz has reviewed thousands of CVs and interviewed countless candidates.In this session, she breaks down exactly how to position yourself as a high-value candidate, on paper, on LinkedIn, and in interviews, so you can stand out and get hired in 2026.What We Cover:How to turn your CV into a value-focused marketing toolStructuring experience with measurable impactTailoring applications to stand outOptimising your LinkedIn profile for visibility and recruiter searchesPreparing confident, structured interview answersKey Takeaways:Focus on outcomes, not responsibilitiesUse metrics to prove your impactCustomisation beats generic applicationsStrong LinkedIn presence increases opportunitiesPreparation and clarity are the foundation of interview successWhy Listen:Get practical, insider advice to strengthen your CV, boost your LinkedIn visibility, and approach interviews with confidence, so you stand out and position yourself as the obvious choice.Show Links:Connect with  Elizabeth Willetts on LinkedIn hereView our career coaching services hereVisit the Investing in Women website here  Boost your career with Investing in Women's Career Coaching! Get expert CV, interview, and LinkedIn guidance tailored for all career stages. Navigate transitions, discover strengths, and reach goals with our personalised approach. Book now for your dream job! Use 'workitlikeamum' for a 10% discount.Support the showSign up for our newsletter and never miss an episode!Follow us on Instagram. Join over 1 million customers and counting who are saving money on their household bills with Utility Warehouse. Discover how much you can save here. And here's your invite to our supportive and empowering Facebook Group, Work It Like a Mum - a supportive and safe networking community for professional working mothers. Our community is full of like-minded female professionals willing to offer support, advice or a friendly ear. See you there!

Discover how NeuroGum's founder turned a college nootropics experiment into a 9-figure brand, dominating Amazon and TikTok Shop and outselling 5-Hour Energy drink at CVS.

Send us a love letter (or hate mail, your choice!)What constitutes stuff vs. things? Easy, boys like stuff, girls like things, and a dream is a wish the heart makes, next question! Meghan and I take to the podcast to settle the stuff vs. things debate, defend the typo, survive a smelly Uber, and drag the completely vibeless CVS on Chicago Ave. Join in, you know you wanna!Get silly with us on social:FOLLOW THE PODCASTInstagram: @pessimisticatbestFacebook: @pessimisticatbestWebsite: pessimisticatbest.comFOLLOW SAMInstagram: @samgeorgsonTikTok: @samgeorgsonTwitter: @samgeorgsonYouTube: @samgeorgsonWebsite: samanthageorgson.comFOLLOW MEGHANInstagram: @meghan.kathrynSupport the show

One Auckland job ad has received more than 2500 applications - and counting. The customer service role with mobile firm Oppo has been listed on Seek.Money correspondent Susan Edmunds has been talking to the man tasked with wading through the CVs and spoke to Ingrid Hipkiss.

This episode is a delightful mixed bag—in the best possible way. We've got two very different low-tech demos, a juicy tech update for the gadget lovers, and one topic that surprised even us. Think of it like Kim's column in Our Special from National Braille Press—something for every skill level. So buckle up. This ride has range.

Tony opens the show by talking about his trip to McDonald's, and he also talks about going to CVS to get some decongestant spray. Michael Wilbon calls in to talk about the NBA All Star Weekend, Kansas State firing their coach with cause, the Daytona 500, and about Collin Morikawa winning at Pebble. Pat Forde calls in from Cortina Italy to talk about what's stood out to him so far at the Olympics, and Tony closes out the show by opening up the Mailbag. Songs : Hotell “Intro” ; “Get In Line” To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

When companies use realistic job simulations, they can finally see beyond CVs and surface true talent, regardless of background. Removing bias from recruitment isn't theoretical; it's achievable. Grounding hiring decisions in real-world, data-driven simulations gives every candidate a fair shot and helps teams identify who will actually succeed in the role. Smart hiring isn't about who interviews best. It's about who performs best. Stephane Rivard, CEO and co-founder of HiringBranch, a Montreal-based company using AI and job simulations to transform high-volume recruitment, shares the evolution of Hiring Branch, why traditional interviews fall short, and how data-driven, skill-based hiring can result in fairer, and more consistent outcomes. Other topics we covered in our conversation: Evolution from language and soft-skills training to data-driven, skills-based assessments. Why success in customer-facing roles goes beyond empathy to skills like rapport, grit, and critical thinking. The difficulty of replacing traditional interviews and reducing bias in hiring. How HiringBranch adapts its platform across industries using deep, role-specific data. Go-to-market insights: experimentation, conferences, networking, and customer outcomes. Advice for HR tech firms on partnerships, focus, and differentiation. And much more! If you're interested in fair and effective hiring practices, data-driven HR, or the future of skills assessment, this conversation offers a grounded, experience-based look at what works and what's changing in the world of recruitment. Website: www.hiringbranch.com LinkedIn: www.linkedin.com/in/stephane-rivard-entrepreneur Check out this B2B podcast launch service. About The A Better HR Business Podcast The A Better HR Business shares strategies, tactics, success stories, and more about marketing for HR consultancies and marketing for HR tech companies, and how to get more clients. Follow the show on Apple Podcasts or Spotify so you don't miss future episodes. For show notes and to see details of our previous guests, check out the podcast page here: www.GetMoreHRClients.com/Podcast HR BUSINESS GROWTH RESOURCES Get the new book - Grow A Successful HR Business Your Way Launch your own business podcast: B2B Podcast Agency VISIT GET MORE HR CLIENTS Want more clients for your HR-related consultancy or HR Tech business? Visit the Get More HR Clients website for articles, newsletters, podcasts, videos, resources, and more at www.getmorehrclients.com.

Dr. Natalie Crawford, board-certified OB-GYN and REI, answers your fertility questions. 1. I'm wondering how alcohol affects male and female fertility, and whether cutting back or abstaining can improve our chances with IVF or natural conception. 2. My wife has low estrogen, and we're trying to conceive. What should we know before her upcoming doctor's appointment so we can ask better questions? 3. We've been trying for 3 years with Clomid and no success. Our doctor suggested a sperm analysis, but we only have access to a CVS kit — are those reliable? 4. I take CoQ10 while trying to conceive — should I take it all month, and do I stop during the two-week wait since it's not recommended in pregnancy? 5. My partner has low motility. How often should we have sex during my fertile window — and am I ‘using up' good sperm if we start too early? We conceived once but lost the baby, and I'm struggling to feel confident. Pre-order Dr. Crawford's debut book, The Fertility Formula, now! ⁠⁠⁠⁠https://www.nataliecrawfordmd.com/book⁠⁠⁠⁠ Want your questions answered on the next episode? ⁠Ask them here!⁠ ⁠⁠https://www.nataliecrawfordmd.com/qa-submissions⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the Franchise Fit Podcast! In this episode, I'm joined by Brian & Michael Appell—the guys behind a national pavement striping, maintenance, and seal coating business trusted by major brands like Costco, McDonald's, Starbucks, CVS, Verizon, Walgreens, T-Mobile and more.We talk about building a “need, not a want” B2B business, what it really costs to start, the biggest mistakes new owners make, how they use AI + tech to win jobs faster, and what they look for in franchisees.

Welcome back to the Alt Goes Mainstream podcast.The Goldman Sachs Alternatives Summit “convened leaders across finance, geopolitics, technology, and culture” to discuss themes driving global markets.2025's Alternatives Summit was about “navigating a world in flux,” as the firm's recap of its event noted. The event aimed to help investors cut through the noise and put together the pieces of the puzzle in a dynamic and increasingly complex world. Alt Goes Mainstream joined the event to have unscripted conversations with Goldman Sachs Alternatives leaders to cut through the noise by unpacking key themes and trends at the intersection of private markets and private wealth.In this special series, we went behind the scenes and interviewed six Goldman Sachs Alternatives leaders about their current thinking on private markets and how the firm has built and evolved its private markets capabilities.This conversation was with Harold Hope, Partner, Global Head of Vintage Strategies, one of the world's largest secondary fund managers, in the External Investing Group (XIG) within Goldman Sachs Asset Management. He is also Chair of the XIG Vintage Funds Committee and a member of the XIG Real Estate Strategies Investment Committee and the XIG GP Strategies Investment Committee. Harold joined Goldman Sachs in 1999 as an Associate in Leveraged Finance and Corporate Finance within the Investment Banking Division and moved to the Alternative Investments & Manager Selection (now XIG) private equity business in 2001. He was named Managing Director in 2006 and Partner in 2016. Prior to joining the firm, Harold worked as a financial analyst at the investment banking boutique Bowles Hollowell Conner & Co. Harold earned a BA in Economics and Political Science from the University of North Carolina. Harold and I had a fascinating and timely conversation about the growth and evolution of the secondaries market. We discussed:Perspectives from Harold's early days in secondaries 25 years ago, when Goldman had raised its first $400M fund in secondaries and when the secondaries industry was doing around $2B per year in transaction volume.How the secondaries market is vastly different from five years ago. The evolution of innovation in the secondaries market.Why problem-solving is a defining feature of secondaries. What is the right skillset required to be a great secondaries investor?Why secondaries is fundamentally a valuation oriented business.Are secondaries returns driven by buying high-quality assets or by buying at steep discounts?Misconceptions about continuation vehicles and how the trend of private companies staying private longer impacts CVs.The how and the why behind Goldman's recent acquisition of Industry Ventures and why Goldman is excited about the opportunity set in venture and growth secondaries.Why scale matters in secondaries.Why secondaries might not become a traded market like the bank loan market and why secondaries may not fully achieve standardization because managers may not want completely uniform standardization.Why secondaries can be an on-ramp to private markets for private wealth investors.Thanks Harold for sharing your wisdom, expertise, and passion about secondaries and private markets. Show Notes00:35 Welcome to the Alt Goes Mainstream Podcast01:26 Harold Hope's Background and Entry into Secondaries02:13 Evolution of the Secondaries Market02:30 Drivers of Change in the Market02:43 Innovations in the Secondary Market04:45 Skill Sets Required in Secondaries05:42 Valuation and Investment Strategies07:14 Continuation Vehicles (CVs) Explained09:27 Impact of Private Companies Staying Private Longer10:47 Acquisition of Industry Ventures12:01 Specialized Teams in Secondaries13:14 Goldman's Unique Position in Secondaries14:28 Leveraging Data and AI in Secondaries15:47 Recent Trends and Market Dynamics16:42 Future Growth of the Secondaries Market17:10 Secondaries as an On-Ramp for Retail Investors18:15 Closing Thoughts and Future OutlookEditing and post-production work for this episode was provided by The Podcast Consultant.

At 21 years old, Alex Hashash was managing 15 people and 18,000 hours of temporary nurses every single week.By his early thirties, he had 120 staff. Most of them offshore.But it didn't start with a playbook. It started with 3 am phone calls, traumatic Blackberry ringtones, and weekend rotas that never seemed to end.When his company decided to build an offshore capability, Alex didn't manage it from a distance.He moved to India for eight months to build the team from scratch.Night shifts. Culture clashes. Teaching people who'd never worked in recruitment how to fill nursing shifts at 2 am UK time.He's spent over a decade learning what separates the founders who make offshore work from those who give up after six months.Most treat it like a cost-cutting exercise. They hire one remote person, hope for the best, and blame the model when it fails.Alex took the opposite approach."If someone makes a mistake, it's really easy to blame them because they're so far away. But if that was a colleague on your desk, would you be as harsh?"The problem isn't the talent. It's the leadership.This week on The RAG Podcast, Alex tells the full story.We cover:Why most recruitment founders fail at offshore within six months How to build culture when your team is thousands of miles away The biggest mistake UK consultants make when managing offshore staff Why hiring people without recruitment experience often delivers the best ROI How to structure probation and promotional targets for offshore hires The leadership buy-in you need before going offshore How he scaled to 120 staff with the majority based offshoreThis isn't theory. It's a decade of hard-won experience across three continents.If you've ever wondered whether offshore could work for your agency - or why your previous attempt failed - this episode has the blueprint.--------------------------------------------------------------------Episode Sponsor: AtlasAdmin is a massive waste of time. That's why there's Atlas, the AI-first recruitment platform built for modern agencies.It doesn't only track CVs and calls. It remembers everything. Every email, every interview, every conversation. Instantly searchable, always available. And now, it's entering a whole new era.With Atlas 2.0, you can ask anything and it delivers. With Magic Search, you speak and it listens. It finds the right candidates using real conversations, not simply look for keywords.Atlas 2.0 also makes business development easier than ever. With Opportunities, you can track, manage and grow client relationships, powered by generative AI and built right into your workflow.Need insights? Custom dashboards give you total visibility over your pipeline. And that's not theory. Atlas customers have reported up to 41% EBITDA growth and an 85% increase in monthly billings after adopting the platform.No admin. No silos. No lost info. Nothing but faster shortlists, better hires and more time to focus on what actually drives revenue.Atlas is your personal AI partner for modern recruiting.Don't miss the future of recruitment. Get started with Atlas today and unlock your exclusive RAG listener offer at https://recruitwithatlas.com/therag/--------------------------------------------------------------------Episode Sponsor: HoxoEvery recruitment founder is investing in LinkedIn.Spending thousands on Recruiter licences.Building connections. Posting content. Growing networks.But here's the question almost no one can answer:How much revenue is LinkedIn actually bringing into your business?Most founders have thousands of connections but no clear process to turn that attention into cash.That's the problem we solve.At Hoxo, we help recruitment founders build predictable revenue...

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

For 11 years, I didn't have a real menstrual cycle.I was on hormonal birth control from my teenage years into adulthood, and while it did exactly what it was supposed to do, it also meant I wasn't ovulating, wasn't having a normal menstrual cycle, and wasn't exactly aware of how deeply hormones shape my energy, creativity, mood, libido, and even my confidence.In this episode, I'm expanding on a recent newsletter I shared and walking you through what I learned when my natural cycle finally came back. I break down the four phases of the menstrual cycle, what's actually happening hormonally for me in each phase, and how those shifts show up for me physically, emotionally, and creatively in my work. I also share how tracking my cycle changed the way I plan my life and manage my energy, and also stopped me from spiraling every month when motivation or confidence dip.This is not an anti–birth control episode. The pill is an incredible tool for so many people, and everyone's bodies and needs are different. This is simply my personal experience of reconnecting with my cycle and the unexpected sense of trust, peace, and empowerment that came from finally understanding my body's rhythms.If you've ever felt like you're “bad at routines,” inconsistent, unmotivated out of nowhere, or confused by sudden shifts in how you feel, you're not broken. You're cyclical. And there's wisdom in that.Sponsors:Bayer: Check out Bayer's trusted lineup of products, available at Walmart, CVS, Amazon, and Walgreens.Wedderspoon: Go to https://wedderspoon.com/discount/REAL20 for 20% off your order.Vuori: Get 20% off your first order at Vuroi.com/REALSTUFFMagnetic Me: New customers get 15% off at MagneticMe.comWatch this episode in video form on YouTube: https://www.youtube.com/playlist?list=PLjmevEcbh5h5FEX0pazPEtN86t7eb2OgX To apply to be a guest on the show, visit luciefink.com/apply and send us your story. I also want to extend a special thank you to East Love for the show's theme song, Rolling Stone. Follow the show on Instagram: https://www.instagram.com/therealstuffpod Find Lucie here: Instagram: https://www.instagram.com/luciebfink/ TikTok: https://www.tiktok.com/@luciebfink YouTube: https://www.youtube.com/luciebfinkWebsite: https://luciefink.com/ Subscribe to my free newsletter "The Lucie List" here: https://thelucielist.beehiiv.com/subscribeSubscribe to "The Creator Confidential": http://www.luciefink.com/confidentialExecutive Producer: Cloud10Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

En este episodio de VG Daily, Valentina Orduz y Juan Manuel de los Reyes abordan la emisión del bono a 100 años de Alphabet/Google, una operación rara en el mundo corporativo que abre la conversación sobre cómo las grandes tecnológicas se financian para la carrera de la inteligencia artificial y la infraestructura de largo plazo. Luego, el análisis se traslada al terreno macroeconómico con los movimientos recientes de los precios de importaciones y exportaciones de Estados Unidos y las cifras de ventas minoristas, usando estos datos para entender mejor la dinámica de inflación, demanda interna y la solidez del consumidor. Finalmente, el episodio cooncluye conectando el panorama macro con el mundo corporativo a través de los reportes de Coca-Cola y CVS, dos compañías ligadas al consumo cotidiano que sirven como termómetro del bolsillo y de los cambios en hábitos de gasto. 

Originally aired May 25, 2023, this episode is rebroadcast in memory of Elly Alboim: an uncommon mind and a rare presence. Elly was brilliant, incisive, and deeply generous as a mentor and with his counsel. For anyone lucky enough to work with him, Elly was the person who could see the whole board at once. He was the person you wanted to speak last in a meeting because his opinion simply mattered most. This episode captures that gift in full for our audience. Elly died at the age of 78. ***The Herle Burly was created by Air Quotes Media with support from our presenting sponsor TELUS, as well as CN Rail, Bruce Power, and AltaGas.***ORIGINAL POD DESCRIPTION: We're bringing together 2 people —  “The Interns” — who mean a helluva lot to me in both a professional and personal sense. As mentors, colleagues, advisors and friends.Elly Alboim and Bill Fox are here!Both Elly and Bill are now 2-time Herle Burly guests. An honorific I'm assuming will go right to the top of their CVs. But listen up to their bona fides: Elly was a journalist for the CBC for almost a quarter century, before becoming Parliamentary Bureau Chief for TV news and National Political Editor. He was a senior advisor to Paul Martin as well as Kathleen Wynne. Today he's an Associate Professor of Journalism at Carleton and a Principal at Earnscliffe Strategies. And he wrote a fantastic piece on today's topic, called “Eliminating the CBC”, which you can check out at Air Quotes Media. Bill began as working journalist and became Ottawa and Washington bureau chief for The Toronto Star. He then turned his eye toward politics as Director of Communications for Prime Minister Brian Mulroney. Today, he's got about 18 academic degrees from small shops like Harvard and Carleton, and he's a leading analyst of media and communication. His latest book is “Trump, Trudeau, Tweets, Truth: A Conversation” which is a fantastic read.We're going dive into a topic that's become quite the political battleground over the last little while: The role and importance of CBC news … How the news division is performing … the case for dismantling … other legitimate journalistic alternatives … but first, media coverage of China election interference.

This show has been flagged as Clean by the host. These are the commands mentioned in the You may need to use "sudo" to run these commands depending on how your system is configured. strace uptime strace ls 2>&1 | grep open strace -e openat ls / strace ls /does/not/exist strace -o ls-trace.log ls strace -ff -o pid12345-trace.log -p 12345 HISTORY The original strace was written by Paul Kranenburg for SunOS and was inspired by its trace utility. The SunOS version of strace was ported to Linux and enhanced by Branko Lankester, who also wrote the Linux kernel support. Even though Paul released strace 2.5 in 1992, Branko's work was based on Paul's strace 1.5 release from 1991. In 1993, Rick Sladkey took on the project. He merged strace 2.5 for SunOS with the second release of strace for Linux, added many features from SVR4's truss(1), and produced a ver‐ sion of strace that worked on both platforms. In 1994 Rick ported strace to SVR4 and Solaris and wrote the automatic configuration support. In 1995 he ported strace to Irix (and became tired of writing about himself in the third person). Beginning with 1996, strace was maintained by Wichert Akkerman. During his tenure, strace development migrated to CVS; ports to FreeBSD and many architectures on Linux (including ARM, IA-64, MIPS, PA-RISC, PowerPC, s390, SPARC) were introduced. In 2002, responsibility for strace maintenance was transferred to Roland McGrath. Since then, strace gained support for several new Linux architectures (AMD64, s390x, SuperH), bi- architecture support for some of them, and received numerous additions and improvements in system calls decoders on Linux; strace development migrated to Git during that period. Since 2009, strace has been actively maintained by Dmitry Levin. During this period, strace has gained support for the AArch64, ARC, AVR32, Blackfin, C-SKY, LoongArch, Meta, Nios II, OpenRISC 1000, RISC-V, Tile/TileGx, and Xtensa architectures. In 2012, unmaintained and apparently broken support for non-Linux operating systems was removed. Also, in 2012 strace gained support for path tracing and file descriptor path decoding. In 2014, support for stack trace printing was added. In 2016, system call tampering was implemented. For the additional information, please refer to the NEWS file and strace repository commit log. Links https://strace.io https://en.wikipedia.org/wiki/Strace https://www.man7.org/linux/man-pages/man1/strace.1.html Provide feedback on this episode.

Full episodes and much more available on Patreon.com/slopquest Comedian Ryan O’Neill and Illustrator Andrew DeWitt bring you the dumbest takes on news, movies and ridiculous business ideas every week on Slop Quest! There’s a little Tina Turner talk at the start of the show. Ryan has a series of injuries when his luck runs out. Andy has a 14 hour delay on a flight. Ryan has his mind blown when he finds out lots of Bible Belt Christians don’t consider Catholics Christian. Then Andy attends a sword fighting class behind a CVS. Andy hides most of Reddit from himself. Then Andy recalls a product for getting lap dances that are just rubber underwear with lube in them. Ryan can’t believe that sexual surrogates are real. Ryan tries to figure out why Airforce Amy was a popular sex worker. Then the boys talk about Bill Gates a bit. Then Andy finds out how many dudes in their thirties have to be on viagra. O’Neill works out at an elementary school playground in Texas.

In this episode of The Option Block, Mark Longo, "Uncle" Mike Tosaw, and Andrew "The Rock Lobster" Giovinazzi dive into a wild week of market reversals, Super Bowl takeaways, and a legendary 80s trivia question that leads to some... interesting historical discussions. The panel breaks down the shift in the AI narrative—from "unlimited upside" to "unlimited spending"—and what it means for the Mag Seven. Plus, they explore the unusual activity in cheap biotechs and the risks of trading wide markets where you might just get "punched in the face" by the spread. In This Episode: The 80s Trivia Challenge: A "Steelers choice" round featuring a badly aimed tomahawk and a controversial question about where Hitler wrote Mein Kampf. The Trading Block: S&P 500 resiliency, VIX hovering near a million contracts a day, and the defensive masterclass of the Super Bowl. AI & The Creative Destruction: Why the "Mag Seven" might be losing their grip as massive AI infrastructure spending begins to weigh on tech giants like Google, Amazon, and Microsoft. Odd Block: Unusual activity in Mura Therapeutics (NMRA)—is it a bullish risk reversal or a market maker's trap? Strategy Block: Uncle Mike discusses the discipline of "having your cake and eating it too" with covered calls and when to exit for 97% profit. Around the Block: A look ahead at non-farm payrolls, the launch of single-name zero-day options (0DTE), and upcoming earnings for Coke, CVS, Robinhood, and the "dumpster fire" that is Ford.

In this episode of The Option Block, Mark Longo, "Uncle" Mike Tosaw, and Andrew "The Rock Lobster" Giovinazzi dive into a wild week of market reversals, Super Bowl takeaways, and a legendary 80s trivia question that leads to some... interesting historical discussions. The panel breaks down the shift in the AI narrative—from "unlimited upside" to "unlimited spending"—and what it means for the Mag Seven. Plus, they explore the unusual activity in cheap biotechs and the risks of trading wide markets where you might just get "punched in the face" by the spread. In This Episode: The 80s Trivia Challenge: A "Steelers choice" round featuring a badly aimed tomahawk and a controversial question about where Hitler wrote Mein Kampf. The Trading Block: S&P 500 resiliency, VIX hovering near a million contracts a day, and the defensive masterclass of the Super Bowl. AI & The Creative Destruction: Why the "Mag Seven" might be losing their grip as massive AI infrastructure spending begins to weigh on tech giants like Google, Amazon, and Microsoft. Odd Block: Unusual activity in Mura Therapeutics (NMRA)—is it a bullish risk reversal or a market maker's trap? Strategy Block: Uncle Mike discusses the discipline of "having your cake and eating it too" with covered calls and when to exit for 97% profit. Around the Block: A look ahead at non-farm payrolls, the launch of single-name zero-day options (0DTE), and upcoming earnings for Coke, CVS, Robinhood, and the "dumpster fire" that is Ford.

Pour ceux qui souhaitent rejoindre la #TribuESOA c'est par ici : https://bit.ly/TribuESOAVoici ce que vous obtenez en rejoignant la tribu ESOA :✅ Echangez quotidiennement avec Kahi, Moulaye pour co-construire le podcast mais aussi sur vos difficultés, interrogations et l'actualité en toute simplicité !✅ Accès d'un an à la communauté privée ESOA (La tribe): un réseau exclusif de 200 membres dans 15 pays entrepreneurs et professionnels africains partout dans le monde pour développer votre réseau, échanger, et vous entraider.✅ Accès à tous nos Masterminds, Book Clubs, Meetups, et événements ESOA exclusifs et à tarifs réduits: participez à des sessions interactives avec Kahi, Moulaye, et des experts invités pour enrichir vos connaissances et votre réseau.✅ Le Template du Life Plan de Moulaye et Kahi: des outils concrets pour clarifier vos objectifs professionnels et personnels, adaptés à tous les profils.✅ Le Replay unique du Mastermind du 18 Décembre “Construire son plan de vie” : un contenu exclusif pour vous guider dans la création de votre plan de vie et de carrière.---------Le Podcast "#Entrepreneur State Of Africa" dit tout haut ce que les #entrepreneurs pensent tout bas, avec Kahi Lumumba (Co-Founder & CEO Totem Experience, Adicomdays) et Moulaye Tabouré (Co-Founder & CEO de ANKA (ex-Afrikrea) ). Dans cet épisode, Kahi et Moulaye reçoivent Fabien PITTÉ-HADDAD, fils, neveu et frère de pharmaciens qui après avoir étudié aux US et travailler dans les grand groupes comme CVS , est renté pour être aujourd'hui Director Of Development du groupe LONGCHAMP (Pharmacie et Laboratoire). -----Ce podcast est produit par Totem Factory by Totem Experience que vous pouvez joindre pour tous vos besoins de production

Kiera is joined by the tooth-healer himself, Jason Dent! Jason has an extensive background in pharmacy, and shares with Kiera where his pharmaceutical experience has bled over into dentistry. This includes the difference between anti-quag and anti-platelet and which medications are probably safe, what to do to shorten the drag time in the pharmacy, how to write prescriptions most efficiently, and more. Episode resources: Subscribe to The Dental A-Team podcast Schedule a Practice Assessment Leave us a review Transcript: The Dental A Team (00:00) Hello, Dental A Team listeners. This is Kiera and today is a really awesome and unique day. It is, think the second time I've had somebody in the podcast studio with me live for a podcast and it's the one and only Jason Dent. Jason, how are you? I'm doing well. Good morning. Thanks for having me. It is crazy. I I watch Instagram real like this all the time where people are like in the podcast and they're hanging out on two chairs and couches and now look at us. We're doing it. Cheers. Cheers.   That was a mic cheer for those of you who are only listening, but yeah, Jace, how does this feel to be on the podcast? It's weird. Like I was not nervous at all talking about it. I got really nervous as soon as you hit play. So if I stumble over my words, please forgive me ahead of time. Well, Jason, I appreciate you being on the podcast because marketing had asked me to do a topic about teledentistry and I was like, oh shoot, that's like not my forte at all. so   You and I were actually chatting in the hot tub. call it Think Tank session and you and I, we have a lot of good ideas that come from that Think Tank. A lot of business. no phones. That's why. We do leave our phones out. But I was talking to Jason and this is actually a podcast we had talked about quite a while ago. Jason has a lot of information on pharmacy. And if you don't know, Jason isn't really, we were going through all of it last night. It's kind of a mock in the tub. And I think it's going to be great because I feel like this is an area, I'm working at Midwestern and   knowing about how dentists, pharmacology was surely not your favorite one. Jason actually helps a lot of dentists with their clearances. And so we were talking about it and I like it will just be a really awesome podcast for you guys to brush up on pharmacology, different things from a pharmacist's side. So Jason, welcome. Thank you. Yeah, no, we were talking about it and here's like, what should I talk about on the podcast next? I have all these different topics and she's like, what do you know? And the only real interaction I have with dentists is doing clearances for procedures. We get them all the time, which makes sense.   Lots of people are on blood thinner, I've always told Kiera, like, hey, I could talk about that. Like, that's kind of a passion of mine. I'm not a dentist. Or my name is Jason Dent. So in Hebrew, Jason means tooth. No, no, no, sorry. Nerves are getting to me. Jason means healer and Dent means tooth. So my name means tooth healer. So, here's a little set. Hold on, on, hold Can we just talk about? I brought that up before you could talk about it more. So.   My name means tooth healer but I did not become a dentist. I know you wanted me to become a dentist. did. I don't know why. I enjoy medicine. I know what you're going to get to already. The things you're going to ask me. There's been years of this. But nevertheless, that's my name. We'll get that out of the way. But you did give me a great last name. So I mean, it's OK. You're All is fair and love here. SEO's up for that. But yeah, Jason, I'm going to get you right into the show. And I'm going to be the host. And we're going to welcome to the podcast show. Jace, how are you?   Good, good, good. Good, good, good. So by getting into clearances, right? This is what you're kinda talking about with you know, before we get to clearances, I actually wanted Jason, for the listeners who don't know you, who haven't talked to you, who don't know, let's kinda just give them like, how did you go from, Kiera wanted you to be a dentist, to now Jason, you are on the podcast talking as our expert on pharmacy. fantastic. I've always really loved medicine, a ton. As a kid getting headaches and taking Excedrin, like you just feel like a miserable pile of crap.   and then you take two pills and all of a sudden you feel better. Like that's amazing, like how does that happen? Also getting ear aches as a kid, just being in so much pain and then taking some medicine and you start feeling a lot better. I always had a lot of appreciation for that. I've always been mechanically inclined. I went to, started doing my undergrad and took biology and learned about ATP synthase, which is a spinning enzyme that's inside the mitochondria, like a turbine engine. I used to work on small engines on my dirt bike and thought that is so cool. So I really got wrapped up into chemistry.   All the mechanics of chemistry really pulled me in. I'm not getting goosebumps. checking. I usually get goosebumps when I think about chemistry. But it's so cool. You think an engine's awesome, like pistons and camshafts and pressures, the cell is the same thing. It's not as loud, so it's not as cool. But it's fascinating. that's why we're like. ⁓   chemistry and really got into coagulation. So I did my residency after pharmacy school. we went to Arizona for three years. ⁓ You did and your main focus, you were never wanting to be the guy behind the counter. No, I haven't done that. Yeah. No, I love them though. I've always really want to go clinical. ⁓ But I love my retail ⁓ pharmacists. They're amazing resources. And ⁓ I use the retail pharmacist every day still to this day, but I went more the clinical route, really love the chemistry aspect of it.   did my doctorate degree and then I did my residency in Reno. Reno's kind That's how we got here everybody. Welcome to Reno. Strategically placed because I was really interested in critical medicine and where we're located we cover a huge area. So we pull in to almost clear, we go clear to Utah, clear to California, all of Northern Nevada. We get cases from all over. So we actually are kind like the first hub of care for lot of areas. So we really get an eclectic mixture of patients that come in that need-   all kinds of different cases that are coming to them. So it's what I really wanted. So I did my residency in critical care there. And then for the next 10 years, I worked in vascular medicine with my final five years being the supervisor of the clinic. Ran all the ins and outs of that. So my providers, two doctors were on our view. So when we talk about dentistry, talk about production, those kinds of things, totally get it. My doctors were the exact same way, my vascular providers. ⁓   There's some pains there, right? You wanna be seeing patients as much as possible, being able to help as many people, keeping the billing up. And had other nurse practitioners, four practitioners, a fleet of MAs, eight pharmacists. We also had that one location we had, going off the top of my head, I think we had eight locations running as well. And we took care of all the different kinds of vascular cases that came to us. Most common was blood clots, ⁓ which is just a...   which is an easier way of saying VTE. There's so many different ways to say a blood clot. Like you might hear patients say, I've had a PE or a DVT or a venous thromboembolism or a clot in my leg, right? They're all clots, but in different locations. Same with an MI, and MI can be a clot as well. ⁓ there's a lot of, everybody's kind of saying the same thing, but sometimes the nomenclature can make it sound hard, but it really is actually pretty simple.   No. And Jason, I love that you went through, you've been in like, and even in your, ⁓ when you were getting your doctorate, you were in the ER. You also worked in retail pharmacy. remember you having a little sticker on your hand. And retail pharmacy, I have a lot of respect for those guys. They have a lot of pressure on them. and then you also, ⁓ what was that test that you had to take that? I don't know. You were like studying forever for it. ⁓ board certification for, ⁓ NABP. Yeah. So I did that board certification as well.   And now you've moved out of the hospital side onto another section in your career. Now in the insurance, right? So it's really, really interesting. So now I'm on the other side reading notes and evaluating clinical appropriateness and trying to help patients with getting coverage and making those kinds of determinations. So yeah, I've really jumped all over. Really love my clinical days. I know. don't I don't I do miss them. But yeah, kind of had a good exposure to a lot of.   pharmacy a lot a lot of dentists actually with all the places that come through which Jason I really appreciate that and honestly I know you are my spouse and so it's fun to have you on but when I go into conversations like this I don't know any of this information and so finding experts and Jason I think here's me talk more about dentistry and my business than I do hear about him on pharmacy so as we were chatting about this I really realized you are a wealth of knowledge because you've been on the clinical side so you've done a lot of patient care and you've seen how   medications interact and I know you've had a few scares in your career and ⁓ you've known some physicians that have had a few scares and ⁓ you've seen plenty of patients pass away working in the ER and gosh in Arizona drownings were such a big deal. I remember when you were in the ER on your rotations I'd be like who died today? Like tell me the stories and you've really seen and now going on to the insurance side I felt like you could just be such a good wealth of knowledge because I know dentists are sometimes so   I would say like maybe just a little more anxious when it comes to medications. I know that dental students from Midwestern were like here was like four months and we had to like pass it, learn it. And Jason, you've done four years plus clinical residency, plus you've been in it. And something I really love about Nevada Medicine is they've been so collaborative with you.   like your heart, your cardiologist, they diagnose and then they send to you to treat with medicine and... Yeah, I've been really lucky being here in Reno too. The cardiology team has been amazing to work with. We started a CHF program, sorry, congestive heart failure program for patients. So we would collaborate with cardiologists. They'd see the cardiologists and then they send them to the pharmacist to really manage all the medications. So there's pillars of therapy ⁓ called guideline directed medical therapy and the pharmacist would take care of all that. So that's gonna be your...   your beta blockers, your ACEs, your ARBs, your Entresto, which would be a little bit better, spironolactone. So just making sure that all these things are dosed appropriately, really monitoring the heart, and make sure that patients are getting better. we've had real positive outcomes when the, sorry, this is totally off topic. do, talk about that study. When we looked at when patients were coming to see our pharmacists in our clinic that we started up, the patients were half as likely to be readmitted. And this was in 2018, and our pharmacists,   We're thinking about all the medications. We're usually adjusting diabetes medications too at the same time. Just kind of naturally just taking care of all the medications because we kind of got a go ahead from the providers, a collaborative practice agreement that we could make adjustments to certain medications within certain parameters. So we weren't going rogue or maverick, but we were definitely trying to optimize our medications as much as possible. And then years later, some studies came out with, I'm sure you've seen Jardins and Farseegh. not trying to, I'm not.   I don't get any kickback from them. I have no conflicts to share. But because our pharmacists were really optimizing that medication, those medications were later shown to reduce hospitalizations and heart failure, even though they're diabetes medications. Fascinating. So it wasn't really the pharmacists. It was just the pharmacists doing as much as they can with all the tools that were in front of them. And then we found out that the patients were going back to the hospital.   half as much as regular patients. So, yeah, being here, it's been so amazing to work with providers here. the providers here want help, want to help patients, don't have an ego. I mean, I just, it's awesome. I love it. I do love how much I think Jason sees me geek out about dentistry and I watching Jay's geek about his pharmacy and how much he loves helping patients. And ⁓ really that was the whole idea of, all right.   Dentistry has pharmacy as a part of it. And I know a lot of dentists are sending in clearances and I know working in a chair side, it would be like, oh no, if they're on warfarin or on their own blood clot, you guys, honestly don't even know half of what I'm talking about because this is not my jam, which is why Jason's here. But I do know that there was always like, well, we got to talk with their provider. And so having Jason come in and just kind of explain being the pharmacist that is approving or denying or saying yes or no to take them off the blood thinners in different parts, because you have seen several dental   I don't know what they're called. What is it? Clarence's? that what comes to you? don't even know. All day my mind, it's like, here is the piece of paper that gets mailed to you to the pharmacist and then you mail it back. So whatever that is. But Chase, let's talk about it because I think you can give the dentist a lot of confidence coming from a pharmacist. What you guys see on that side. When do you actually need to approve or disapprove? Let's kind of dig into that. Yeah. Well, first of all, I think I'm not a replacement for any kind of clinical judgment whatsoever. Every patient's different. But the American Diabetes Association, you   I work with diabetes a lot. American Dental Association has some really great guidelines on blood thinners and I would always reference them. I actually looked at their website today. Make sure I'm up to speed before I get back on this again. They have resources all around making decisions for blood thinners. And I think the one real important thing in putting myself in the shoes of a dentist or any kind of staff that's around a patient that's in a chair, if they say I'm on a blood thinner, right, a flag goes up. At least in my mind, that's what goes up.   Like, okay, how do we get across this bridge? And I think the important thing to really distinct right then when they say they're on a blood thinner is that is kind of a slang word for a lot of different medications, right? Like it's the overarching word that everybody pulls up saying, I'm on a blood thinner. It's like, okay, but I don't know what say. It's like, I have a car. You're like, okay, do you have a Mazda? Do you have?   Toyota, Honda, what do you have? or even worse it'd be like saying I have a vehicle, right? So when somebody says they're on a blood thinner, it opens up a whole box of possibilities of what they're Blood thinners are also, doesn't, when they're taking these types of medications that are quote unquote a blood thinner, it doesn't actually thin the blood, like adding water to the blood, if that makes sense, or like thinning paint, or like thinning out a gravy, right? It doesn't do the same thing. Blood thinners, really what they're doing is they're working on the blood, which.   which is really cool, try not to tangent on that. ⁓ When they're working on the blood, it's not thinning it per se, but it's making it so that the proteins or platelets that are in it can't stick together and make a cloth quite as easy. So whenever somebody's on a blood thinner, I usually ask, what's the name of the blood thinner that you're on? It's not bad that they use that slang, that's okay, on the same page, but it's really broken into two different classes. There's anticoagulant and antiplatelet.   And a way to kind of remember which is which, when residents would come through our clinics, the way that I teach them is a clot is like a brick wall. You know, it's not always a brick wall. Usually the blood is a liquid going through. But once they receive some kind of chemical message, it starts making a brick wall with the mortar, which is the concrete between the and the bricks, the two parts. When it's an anti-quagent, it's working on that mortar part. When it's an anti-platelet, it's working on the bricks part, right? You need both to make a strong clot or strong brick wall.   But if you can make one of them not work, obviously like if your mortar is just water, it's not working, right? You're not gonna make a strong brick wall. So that's kind of the two deviants right there. So that's what I do in my mind real quickly to find out because antiplatelets are usually, so that's gonna be like your Plavix, Ticagrelor, Brilinta. And hold on, antiplatelets are bricks? Good job, bricks. They're the bricks. And so the reason I was thinking you could remember this because I'm, antiplatelets, it's a plate and a plate is more like a brick.   And anti coagulant, I don't know why quag feels like mortar to me, like quag, like, know, it's like slushy in the blood, like it's coagulating. It's a little bit of that, like, honestly, I'm just thinking like coagulated blood is a little bit more mortar-ish. And so platelet is your plate, like a brick, and anti-quag is like.   the gilly between the bricks. Okay, okay, I got it. Yeah, so there's an exception to every rule, but when they're on that Don't worry, this is Kiera, just like very basic. You guys are way smarter listening to this, and that's why Jason's here. No, no, you helped me pass pharmacy school. When we were doing all the top 200, you helped me memorize all know what flexorill is, all right? That's a muscle relaxant. Cyclo? I don't know that part. It's a cyclo, because you guys are cycling and flexing. I don't actually know. just know it's a muscle relaxant, so that's about as far as I got. When we're looking at antitick platelets, so that's the brick part, so that's going to be your, you know,   Hecagrelor, Breitlingta, Clopidogrel is the most common one. It's the cheapest one, so probably see that one the most. Those, I mean, there's an exception to every rule, but that's generally being used after like a stent's placed in the heart. It can be used for VTE, there's some out there, but that's pretty rare. But also for some valves that are placed in the hearts, it can be used for that as well. So antiplatelet, really thinking more like a cardiac event, right? Like I said, there's always an exception to every rule, but that's kind of where my mind goes real quickly, because we're gathering information from the patient.   They're on anticoagulant. Those are like going to be the new ones that you see commercials for all the time. So Xeralto, Alequis, those are the two big ones right now. They're replacing the older one. And also we were supposed to do a disclaimer of this is current as of today because the ADA guidelines do change. this will be current as of today. And Jason, as a pharmacist, is always looking up on that. I had no clue that you are that up to speed on dental knowledge. so just throwing it out there that if you happen to catch his podcast,   a few years back that obviously check those guidelines for sure. But the new ones are the Xarelto and Eloquist. They're replacing the older ones of warfarin. Warfarin's been around for a really long time. We've seen that one. Those are anti-coagulants. So when you're looking, when a patient says that, generally they're on that medication because they've possibly had a clot in the past or they have a heart condition called atrial fibrillation. Those are kind of the two big ones. Like I said, there's always caveats to it, but that's kind of where my mind goes real quickly. And then,   as far as getting patients cleared, the American Dental Association has really good resources on their website. You can look at those and they're always refreshing that up. They even say in their own words that there's limited data around studying patients in the dental chair and with anticoagulants or anti-platelets. It's pretty limited. There's a few studies, some from 2015, some from 2018. There's one as recent as 2021, which is nice. But really, all of those studies come together and it's really more of an expert consensus.   And with that expert consensus, they have kind of simplified things for dentistry, which is really nice. ⁓ comparing that to, we have more data for like total hip replacement, total knee replacement. We have a lot of data and we know really what we should be doing around then. But going back to dentistry, we don't have as much information, so they always say use clinical judgment, but they do give some really great expert guidance on that. So if a patient's on an anticoagulant, ⁓   they generally recommend that it doesn't need to be stopped unless there's a high bleeding risk for a patient. as a provider or as a clinician in the practice, you can be looking at high bleeding risk. Some things that make an oral procedure a little bit lower risk is one, it's in the compressible site, right? Like we can actually put pressure on that site. That's the number one way to stop bleeding is adding pressure. It's not like it's in the abdominal cavity where we can't get in and can't apply pressure. So number one, that kind of reduces the bleeding risk.   is number one. Two, we can add topical hemostatic agents. Dentists would know that better than me. There's a lot of topical ways to do that. So not only pressure, but there's those things as well. And also, but there are some procedures that are a little bit more likely to bleed. And that's where you and dentists would come in hand in What's the word in APO? Oh, the APOectomy. I got it right. Good job. like, didn't you tell me last night that the ADA guideline was like what?   three or four or more teeth? great question. So you can extract one to three teeth is what their expert consensus One to three teeth without. Without really managing or stopping anticoagulation or doing anything like that. I think that's some good guidance from them. I'm gonna add a Jasonism on that though. So with warfarin, I do see why dentists would be a little bit more conservative or worried about stopping the warfarin because warfarin isn't as stable as these newer agents. Warfarin, the levels.   quote unquote levels can go really high, they can go really low. And if the warfarin levels are high, they're more likely to bleed. So I do think it makes sense to have a really recent INR. That's how we measure what the warfarin's doing. I think that makes a lot of sense, but the ADA guidelines really go into the simplification version of all these blood thinners. Generally, it's recommended to not stop them because the risk of stopping them outweighs the benefit of stopping them in almost every case. Almost every case.   ⁓ So when you're with that patient, right, they say I'm on a blood thinner, finding out which kind of blood thinner that they're on, you find out that they're on Xeralto, right? How long have you been on Xeralto for? I've been on it for years. You don't know exactly why, but if they haven't had any recent bleeding, you're only gonna remove one tooth. ⁓ You can do what's called a HasBlood score. That kind of looks at the bleeding risk that they'd have. That'd be kind of going a notch above, but in my mind, removing one tooth isn't a real serious bleeding risk. I'd love to hear from my dentist friends if they...   disagree, right, but ADA says one to three tooth removals, extractions, that's the fancy word. Extractions, yeah, for extracting teeth out. Is not really that invasive. Sure. It's not that high risk, so it's usually perfectly fine. So if a patient was on Xarelto, ⁓ no other, this is in a vacuum, right? I'm not looking at any other factors, which you should be looking at other factors. I would be perfectly fine to just remove one to two.   And when those clearances come in, because dentists do send them, talk about what happens. You guys were working in the hospital and you guys would get these clearances all the time. do. We get them so often. I mean, we get like four or five a day. We'd love to give it to our students, student pharmacists, and ask them what to do. And they would usually look up the American Dental Association guidelines and come up with something. We're like, yep, that's what we say too. In fact, we say it so many times a day that we have a smart phrase.   which just blows in the information real quickly and faxes it right back to the So it's like a copy paste real quick. So what I wanted to point out when Jason told me this is dentists like hearing this and learning this, this can actually save you guys a ton of time to be able to be more confident, to not need to send those clearances on. And we were actually talking last night about how I think this might be a CYA for dentists. like, as we were talking, I think Jason, you seeing so many other aspects of medicine, like you've literally seen patients die, you've seen other areas.   And so coming from that clinical vantage point, we were realizing that dentists, we are so blessed to live in an injury. I enjoy dentistry because possibly there's someone dying, not super high, luckily in dentistry. The only time that I have actually had a doctor have a patient pass away, and it was only when they were completely sedated and doing ⁓ some other things, but that was under the care of an anesthesiologist. And so that's really our high, high risk. And so hearing this, Jason,   That was one of the reasons I wanted him to come on is to give you doctors more confidence of do we have to always send to a pharmacist? I mean, hearing that on the pharmacy side, they're just sending these back and not to say to not see why a to not cover this because you might be questioning like, well, do I really need to? But you also were talking about some other ways of so number one, you guys are just going to copy back the 88 guidelines. So so 88 guidelines. Yeah. And I think that that gives a lot of confidence to a provider or a dentist is that you can go to the 88 guidelines and read them, right? Like you're listening to some   nasally monotone pharmacist on a podcast. Rumor has it, people love him at the hospital. were like, you're the voice, he's been told he has a good radio So for the clinic, I was the voice. Like, yeah, you've reached the vascular clinic, right? And they're like, oh my gosh, you're the voice. But sorry, you me distracted. That'll be your next career, Jace. You're going to be a radio host. OK. I would love that. I love music. But you're hearing from a nasally guy, but you can actually read the ADA guidelines. You just go right to the ADA, click on Resources, and under Resources, it has the   around anticoagulants, I think that's the best way to get a lot of confidence about it because they have dentists who are the experts making calls on these. I'm just reiterating what they say, but I think it makes a lot of sense to help providers. And the reason why my heart goes out to you as well is having the providers that used to work underneath me, they're always looking for our views, which is a fancy way of making sure that they're drilling and filling. Can I say that? Yeah, can say drilling and filling. They're being productive, right? They're being productive, right?   They're always looking to make sure if a patient's canceling, like get somebody in here. Like I need to be helping people all day long. That's how I, we keep the lights on. That's how I help as many people. And so if you have a patient coming in the chair and it has an issue, they say I'm on Xeralto. Well, you can ask real quickly, why are you on Xeralto? I had a clot 10 years ago. my gosh. Well, yeah, we're pretty good to go. Then I'm not worried. We're only removing one tooth or we're just doing a cavity or a cleaning. Something like that. Shouldn't be an issue whatsoever because there's experts in the dental. ⁓   in the dental society, the ADA guidelines that recommend three teeth or less, minimally invasive. They really recommend if it's gonna be really high bleeding risk. And clinically, that's where you would come in, ⁓ or yourself. know, apioectomy is one that's like on the fence line. I don't know where implants set. though, and like we were talking, implants aren't usually like a date of procedure. Most people aren't popping in, having tooth pain, and we're like, let's do an implant. Now sometimes that can be the case, but typically that one's gonna have   a few other pieces involved. And so that is where you can get a clearance if you want to. ⁓ But we were really looking at this of like so many dentists that I know that you've seen will just send in these clearances because they are. And I think maybe a way to help dentists have more confidence is because you know, I love routines. I love to not have to remember things. So why don't we throw it in, have the team member set it up where every quarter we just double check the ADA guidelines. Are there any updates? Are there any other things that we need to do on that? That way you can just see like   getting into the language of this, of what do I need to do? Because honestly, you guys, know pharmacy was not a big portion for it, so, recommending different parts, but I think this is such a space where you can have confidence, and there's a few other things I wanna get to, and I you- I some pearls too. Okay, go. I'm so when she get me into talking about drugs, I'm not gonna stop. So, some other things around that too is these newer blood thinners like Xarelto Eloquist, they now have reversal agents, so a lot of providers in the past were really worried about bleeding because we can't turn it off. We can turn those off. Warfarin has reversal as well, right?   So I'm looking at these patients. It's really low risk. It's in the mouth, generally speaking. Very rarely are they a high bleeding risk. Now if you're doing maxillofacial surgery, this does not apply, right? This does not apply whatsoever. you're like general dentist, you're pediatric dentist. Yeah, yeah, and it's kind of on the fly. So just trying to really help you to be able to take care of those patients on the moment, have that confidence, look at the ADA guidelines, have that in front of you. I don't think it's a bad thing to ever...   check with their provider if you need to. If you're thinking, I feel like I should just check with the provider, I would never take that away from you. But I just want to kind of steer towards those guidelines that I have to help. But what did you want to share? No, yeah, I love that. And I think there were just a few other nuggets that we were chatting about last night that can help dentists just kind of get things passed a little bit easier. So you were mentioning that if they were named to their cardiologist, what was it? was like, who is the last? Great question. Yeah, when a patient's on a blood thinner,   It could be prescribed by the cardiologist. It could be prescribed by the family provider or could have been punted to like a vascular clinic like where I was working. It can go to any of those. And when you send that fax, right, if it goes to the cardiologist and it's supposed to go to the family care provider, like it just kind of goes, goes nowhere, right, from there. So I think it's a really good idea to find out who prescribed it last. If the patient doesn't know who prescribed their blood thinner last, you can call their pharmacy. I call pharmacies all day long.   I have noticed in the last year, they are way easier to get a hold of, which has made my job a lot easier, working on the insurance portion. So reaching out to the pharmacy, finding out who that provider is and sending it to them, because they should be able to help with that. I thought that was a good shift in verbiage that you had of asking instead of like the cardiologist, because that's who you would assume was the one. But you said like so many times you guys would take care of them, and then they go back to family practitioner, and you guys would get the clearances, but you couldn't clear because you weren't overseeing. So just asking the patient.   who prescribed their medication for them last time. That way you can send the clearance to the correct provider. then- And they might not know. You know patients, right? They're like, I don't know, my mom's or else, I don't know who gave it to me. Somebody told me I need to be on this. But at least that could be another quick thing. And then also we were talking last night about-   ⁓ What are some other things that dentists can do when like writing scripts to help them get what I think like overarching theme of everything we discussed is one how to help dentists have less I think drag through pharmacy. ⁓ Because pharmacy can take a little while and so perfect we now know the difference between anti-quag and anti-platelet. We know which medications are probably safe. We know we can check the ADA guidelines so that we were not having to do as many clearances. We also know if they're on a medication to find out and we do need a clearance.   who we can go to for the fastest, easiest result. And now, in talking about prescriptions, you had some really interesting tips that you could share with them. Yeah, so with writing prescriptions, right, pharmacies are pharmacies. So I'm not gonna say good thing or bad thing. There are challenges working with pharmacies. I'm not gonna play that down at all. ⁓ If you're writing prescriptions and having issues and kickbacks from pharmacies, there's some interesting laws around ⁓ writing prescriptions. Say that you're trying to ⁓ prescribe   augmentin, you know, 875 BID, and you tell the patient, hey, I want you to take this twice a day for seven days, and then you put quantity of seven, because you're moving fast, right? You want it for seven days, quantity of seven. Quantity would actually be 14, right? It's not that big of a deal. Anybody with common sense would say if you're taking a pill for twice a day for seven days, you need 14 tablets. But LAHA doesn't allow pharmacists to make that kind of a change, unfortunately. They have to follow what you're saying there. So you're going to get a...   An annoying callback that says, you wrote for seven tablets. I know you need 14. Is that OK? Just delays things, right? So ⁓ I really like the two letters QS. That's Q isn't queen. S isn't Sam. Yeah. It stands for quantity sufficient. So you don't have to calculate the amount of any medication that you're doing. So for me, as a pharmacist, when I was taking care of patients, I hated calculating the amount of insulin they would need for an entire month. So I would say.   Mrs. Jones needs 15, I'd say 15 units ⁓ QD daily. ⁓ And then I say QS, quantity sufficient, ⁓ 90 day supply through refills. So the pharmacy can then go calculate how much insulin that they need. I don't have to even do that. So anytime you're prescribing anything, I like that QS personally. So that lets the pharmacy use ⁓ common sense, as I like to call it, instead of giving you a call. I think that's super helpful. I also thought of one thing too.   going back to blood thinners is when it's kind of like a real quick, like they're not gonna have you stop the blood thinner at all. like you're seeing if you can stop the blood thinner for a patient, there's some instances it's just not gonna happen. And that's whenever they've been, they've had a clot or a stroke or a heart attack within the last three months. Three months. Yeah, that's kind of like the.   Because so many people are like, they had a heart thing like six years ago. And so I think a lot of my dentists that I worked with were like, we got to stop the blood thinners. But it sounds like it's within three months. Yeah, well, I'm just the time. Like this is general broad strokes. What I'm just trying to say is when you want to expect a no real quick. Got it. Right. So because benefits of stopping a blood thinner within those first three months of an event is very, very risky versus the, you know, the benefit of reducing a little bit of blood coming out of the mouth. Right. Like that's not that bad.   when somebody's had a stroke or a heart attack or pulmonary embolism, a clot in the lung, like we can't replace the lung, heart or brain very easily. We can replace blood a lot better. We've got buckets of it at most hospitals have buckets of it, right? So I'm always kind of leaning towards I'd rather replace blood than tissue at all times. So that's kind of a quick no. If they've had one those events in the last three months, we are really, really gonna watch their brain instead of getting.   root canal, right? Like really worried about them. So you'll just say no. And they could the dentist still proceed with the procedure or would you recommend like a three month wait? Or is it provider specific way the pros and cons because sometimes you need to get that tooth out. Great question. think then it's going to come into clinical. That's that's when you send in the clearance, right? Like, and it's great to reach out to the provider who's managing it for you. But I think it's kind of good to know exactly when you get a quick no quick no is going to be less than three months.   ⁓ Or when it's going to be like a kind of a typical, yeah, no problem. If it's been no greater than six months, they're on the typical anticoagulants or alto eloquence. Nothing crazy is going on for them. You're only removing two teeth. This is very, very low risk. But again, I'd urge everybody to read the ADA guidelines. That way you feel more comfortable with it. I'm not as eloquent as they do. They do a real good job. So I don't want to take any of their credit. I think they do a real good job of simplifying that and making you feel confident with providing.   more timely care for patients. Which is amazing. And Jayce, one last thing. I don't remember what it was. You were talking about the DEA and like six month rule. yeah. Let's just quickly talk about that and then we'll wrap this because this is such a fascinating thing for me last night. Yeah. So when comes to prescribing controlled substances, most providers have to have a DEA license. OK. First of all, though, what's your take on dentist prescribing controlled substances? ⁓ I don't think, you know, I worked on the insurance side of things. Right. And I look at the requirements for the   as the authorizations, what a patient, the criteria a patient needs to hit in order to qualify for certain medications. A lot of times for those controlled substances, they have pretty significant issues going on, like fibromyalgia or cancer-related pain or end-of-life care versus we don't, in all my scanning thread, I don't have a ⁓ perfect picture memory. Sure. But I don't usually see oral.   pain in there. There is some post-operative pain that can be covered for those kind of medications but I really recommend to keep those lower and in fact in a lot of our criteria it recommends you know have they tried Tylenol first, they tried, have they filled NSAIDs or are they contraindicated with the patient. So really they should be last line for patients in my two cents but there's always going to be a caveat to the rule right? Of course. comes through that has oral cancer and you're taking   like that would make sense to me. Got it, so then back to the DEA. Yeah, okay. Okay, ready. So as a provider, you should be checking the, if you're doing controlled substances, you should be checking the prescription drug monitoring program, or sometimes called the PDMP, looking to see if patients are getting ⁓ controlled substances from another provider. So it's really just a check and balance to make sure that they're not going from provider to provider to getting too many narcotics and causing self harm or harm to others.   And so with checking that PDMP before prescribing, I think a lot of providers do that. A lot of softwares that I'm aware of, EMRs, electronic medical records, sometimes have links so that you can do that more quickly. However, I don't think it's as intuitive that they need to be checking that every six months in some states. And like here in Nevada, you're supposed to be checking it every six months, not for a patient, but for your actual DEA registration to see if anybody else is prescribing underneath you. Because if you don't check that every six months, you could get in some serious trouble with...   not only DEA, but even more the Board of Pharmacy and your state. Now, I don't know all 50 states, so I check with your state to see if you need to be checking that every six months, but set an alarm just to check that real quickly, keep your nose clean. ⁓ I've had providers, I've had to remind to do that. And if somebody was using your account, prescribing narcotics, you'd never know unless you went and checked that PDMP.   Yeah, I remember last night you were like, and if that was you, I would not want to be you. The Board of Pharmacy is going to be real excited to find you. So that was something where I was like, got it. So, and we all know I'm big on let's make it easy. And Jason, I love that you love this so much and you just brought so much value today. And like also for me, it's just fun to podcast. fun. Yeah. But I got a nerd out on my world a little bit. Bring it into yours. I work with dentists or at least you know, when I was working in Vascular Clinic all day long. Great questions that would come through. Yeah.   So I think for all of us, as a recap on this is number one, I think setting yourself ⁓ some cadences. So maybe every quarter we check our ADA guidelines and we check our, what is it, PDMP. PDMP. so each state, so they call it Prescription Drug Monitoring Program. We need that. Yeah, but there are different acronyms in different states, though. That's just what it's called in Nevada. I forget what it is in California, but you can check your state's prescription monitoring program, make sure that opioids aren't being prescribed under your name. Got it. So we just set that as a cadence.   We know one to three teeth most likely if they're on a blood thinner is According to the 88 as of today is good to go You know things that are going to get a quick know are going to be within the last three months of the stroke the heart attack or the Clot I'm thinking like the pulmonary embolus. Yeah, that's what we're trying to prevent   Those are gonna be quick knows and then if we're prescribing, let's do QS. We've got quantity is sufficient so that we're not getting phone calls back on those medications that we are. And then on narcotics, just being a bit more cautious. Of course, this is provider specific and in no way, or form did Jason come on here to tell you you are the clinical expert.   Jason's the clinical expert on medications. And if you guys ever have questions, I know Jason, you geek out and you want to talk to people so that anyone wants to chat shop. Be sure to reach out and we'll be able to connect you in. we've even talked about possibly, so let me know listeners. You can email in Hello@TheDentalATeam.com of ask a pharmacist anything. I talked to Jason. I was like,   We'll just have them like send in questions and maybe get you back on the podcast or we do a webinar. But any last thoughts, Jace, you've got of pharmacy and dentistry as we as we wrap up today? No, I think that's pretty much it. So check the ADA guidelines. I think it's really good to have cross communication between professions. Right. If you're working with the pharmacy, CVS, Walgreens or something like that or Walmart, I know that it can be challenging. Right. They're under different pressures. You're under different pressure. So I think ⁓ just coming in with an understanding, not being angry at each other.   you know what mean, is super beneficial and working together. When it comes to it, every dentist that I've talked to is actually worried about their patient. Every pharmacist that I've worked with is really worried about the patient as well. So we're trying to accomplish the same thing, but we have different rules and our hands are bound in different ways that annoy each other, right? Like I know Dr. Jones, want 14 tablets, but you said seven. And I know Common Sense says I should give them 14, but I've got to make that change.   knowing that their hands are tied by the law. They can't use as much common sense, which is aggravating. I mean, that's why I love what I gotta do here. I gotta just kind of help a lot more and use common sense and improve patient care. But those kinds of things I think are really beneficial as you work together and then not being so afraid of blood thinners, right? So I think those guidelines do a great job of giving you confidence and not worrying about the side effects. And there's a lot of things that you can do locally for bleeding.   You have a lot of control over that. I think that's pretty cool, the tools they have. Yeah. And at the end of the day, yes, you are the clinician. You are the one who is responsible for this. so obviously, chat, but I think collaborating, talking to other pharmacists, talking to them in your state, finding out what are the state laws, things like that I think can be really beneficial just to give you peace of mind and confidence. And again, dentistry, are maybe a bit more risk adverse because luckily we don't have patients dying That's great thing. Yeah, that's fantastic. I want my dentists to be risk adverse. I think so too. But Jason, I appreciate you being on the podcast today.   And for all of you listening, ⁓ more confidence, more clarity, more streamline to be able to serve and help our patients better. if we can help you in any way or you've got more questions, reach out Hello@TheDentalATeam.com. And as always, thanks for listening. I'll catch you next time on the Dental A Team podcast.  

In this episode, I'm finally telling the full story of the spiritual experience that changed my personality and my entire approach to life. It's the story of a dream I had about my late “Uncle” Donald — a man who wasn't biologically related to me, but who was woven into the fabric of my family and my life in a way that's hard to put into words. He was my parents' best friend, the person who introduced them to one another, and someone who felt just as much like family as any blood relative.After he passed away suddenly in 2011, something happened that completely changed the way I understand the world. The night of his funeral, I had a dream that felt different from any dream I'd ever had before — one that has stuck with me more than a decade later.In this episode, I talk about that dream, the strange and meaningful signs that followed, and why I believe he stayed with me (and my family) for a decade after he passed. I share how those signs showed up at major moments in my life — my career, my wedding, becoming a mother — and how they continue to shape the way I move through the world today.This story touches on loss, spirituality, dreams, and the ways we stay connected to the people we love, even after they're gone. I know this kind of story isn't everyone's cup of tea, and that's okay. But for me, it's brought comfort, peace, and a deeper sense of connection to life itself.If you've ever lost someone and wished for a sign, or wondered whether the people we love ever really leave us, I hope this episode resonates with you.Thank you for being here and letting me share this part of my story.Sponsors:Bird&Be: Visit birdandbe.com and use code REALSTUFF for 15% off your first purchase.Laundry Sauce: Get 20% off your entire order at Laundry Sauce with code REALSTUFF at laundrysauce.com/REALSTUFFPique: Unlock 20% off and begin your journey toward sustained wellness today at Piquelife.com/REALSTUFFSKIMS: Shop SKIMS Fits Everybody collection at skims.com/realstuffBayer: Check out Bayer's trusted lineup of products, available at Walmart, CVS, Amazon, and Walgreens.Watch this episode in video form on YouTube: https://www.youtube.com/playlist?list=PLjmevEcbh5h5FEX0pazPEtN86t7eb2OgX To apply to be a guest on the show, visit luciefink.com/apply and send us your story. I also want to extend a special thank you to East Love for the show's theme song, Rolling Stone. Follow the show on Instagram: https://www.instagram.com/therealstuffpod Find Lucie here: Instagram: https://www.instagram.com/luciebfink/ TikTok: https://www.tiktok.com/@luciebfink YouTube: https://www.youtube.com/luciebfinkWebsite: https://luciefink.com/ Subscribe to my free newsletter "The Lucie List" here: https://thelucielist.beehiiv.com/subscribeSubscribe to "The Creator Confidential": http://www.luciefink.com/confidentialExecutive Producer: Cloud10Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome back to the Alt Goes Mainstream podcast.Today's episode dives into the rapidly expanding world of secondaries with a senior leader at one of the pioneering firms in the secondaries space.We sat down at Franklin Templeton's New York office with Taylor Robinson, a Partner on the Secondary team at Lexington Partners, which has over $77B in total capitalization and is part of Franklin Templeton's family of private markets funds and strategies.Taylor, who joined the firm in 2008, is primarily focused on the origination, evaluation, and execution of secondary opportunities, including partnership and GP-led transactions. He's also a member of Lexington's ESG Steering Committee.Taylor and I had a fascinating conversation about the current state of the secondaries market. We covered many of the hot button topics and trends that are shaping the secondaries market, including:Why secondaries have become an integral part of many LPs portfolios.How secondaries have become a portfolio management tool for LPs.The rise of GP-led secondaries.Why not all CVs are created equal.Why secondaries can be a good on-ramp to private markets for wealth channel investors.What the future holds for secondaries.Thanks Taylor for coming on the show to share your expertise and wisdom about private markets and secondaries.Show Notes00:00 A Different Way of Thinking About Private Equity00:43 Welcome to the Alt Goes Mainstream Podcast01:20 Introduction to Taylor Robinson02:35 Taylor Robinson's Background and Career04:25 The Evolution of the Secondaries Market05:20 Impact of the Financial Crisis on Secondaries06:34 Growth and Liquidity in Private Markets07:13 Current State of the Secondaries Market07:29 Traditional vs. GP-Led Secondary Deals09:18 Challenges and Opportunities for Institutional LPs11:22 Active Portfolio Management Strategies13:06 Driving Returns and Gaining Edge14:46 Evaluating and Partnering with GPs16:30 Nuances of the Secondary Market17:22 Market Dynamics and Investment Strategies18:04 The Role of Data and Technology19:35 Regulation and Standardization in Private Markets20:08 Evolving Focus of Secondaries Firms20:51 Investment Horizons and Return Expectations22:17 Primary vs. Secondary Fund Investing27:07 Specialization and Diversification in Private Equity28:41 Managing Favorite Assets28:49 Diversified Portfolio Nuances29:37 Generating Alpha in Secondaries30:22 Asset Selection and Value Drivers31:09 Consistent Investor Experience33:53 Comparing Secondaries and Primaries35:51 Evaluating Secondaries Over Time37:18 Evergreen Funds and New Structures38:11 Benefits of Locked-Up Capital40:34 Challenges in Evergreen Space41:39 Wealth Channel and Scale43:04 Skillset for Secondaries Investors45:16 Intellectual Curiosity and Success47:45 Industry Trends and GP Consolidation49:16 Understanding Market Dynamics50:18 Training and Retention at Lexington50:41 Future of Secondary Markets52:54 Misconceptions About Secondaries54:31 Shifting Mindsets on Discounts54:54 Consistent Returns Through Cycles55:42 Secondaries as a Real Asset Class56:16 Excitement for Future Growth56:22 Conclusion and FarewellEditing and post-production work for this episode was provided by The Podcast Consultant.

Overwhelmed? Take a Breath and Break That Stuff Down Lately, my life has been one big project—moving parts everywhere, big transitions coming, and a to-do list that looks like a CVS receipt. Between preparing to take my practice fully virtual and planning the next chapter of my life, there have been plenty of moments where I've thought, “holy shit, this is too much.” So in this episode, I'm keeping it brutally real about how I deal when everything starts to feel overwhelming. The trick? You stop trying to swallow the whole damn elephant. You take it one bite at a time. Break it down, piece by piece, until it's actually doable. Because here's the truth: overwhelm doesn't mean you're failing—it just means you're human. I'll share how I've been breaking my own chaos into smaller wins, how I stop myself from spiraling, and why control starts with clarity, not perfection. If you're staring down a massive project, a big change, or just life being life—this episode is your permission to slow down, get organized, and remember: you don't have to do it all at once. Just start with one small step and keep going.

A Democratic challenger in Texas District 2 lays out his vision as AOC shreds CVS greed and Don Lemon's arrest exposes the growing crackdown on independent journalism.Subscribe to our Newsletter:https://politicsdoneright.com/newsletterPurchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make AmericaUtopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And BeFit Now: https://amzn.to/3xiQK3K Tribulations of anAfro-Latino Caribbean man: https://amzn.to/4c09rbE

Overwhelmed? Take a Breath and Break That Stuff Down Lately, my life has been one big project—moving parts everywhere, big transitions coming, and a to-do list that looks like a CVS receipt. Between preparing to take my practice fully virtual and planning the next chapter of my life, there have been plenty of moments where I've thought, “holy shit, this is too much.” So in this episode, I'm keeping it brutally real about how I deal when everything starts to feel overwhelming. The trick? You stop trying to swallow the whole damn elephant. You take it one bite at a time. Break it down, piece by piece, until it's actually doable. Because here's the truth: overwhelm doesn't mean you're failing—it just means you're human. I'll share how I've been breaking my own chaos into smaller wins, how I stop myself from spiraling, and why control starts with clarity, not perfection. If you're staring down a massive project, a big change, or just life being life—this episode is your permission to slow down, get organized, and remember: you don't have to do it all at once. Just start with one small step and keep going.

In this powerhouse segment from The Clay Edwards Show, host Clay Edwards sits down with State Rep. Fred Shanks for a no-holds-barred chat on hot Mississippi and national issues. They kick off with the "Kraken" finally unleashing in Fulton County—six years after 2020—with DNI Director Tulsi Gabbard on the ground auditing ballots amid desperate reactions from election officials that scream guilt. Clay and Fred speculate on potential foreign ties (Venezuela? China?) and celebrate the momentum, even floating a bold "Trump 2028" reclaim.   Shifting to local streets, they break down Rep. Shonda Yates' bill to seize vehicles in drag racing busts. As fellow reformed South Jackson car guys, they support hitting organized chaos—like trailer queens flipping on Medgar Evers—while protecting casual enthusiasts from overreach. No more shutting down city blocks for high-stakes bets; it's time for real teeth in enforcement, inspired by JPD and Capitol PD feedback.   Finally, Fred draws from his 30 years as a pharmacist to expose the PBM racket—pharmacy benefit managers owned by big insurers and chains like CVS, clawing back millions and forcing independents to close. They call for transparency and reform to save community lifelines that sponsor Little Leagues, deliver midnight meds, and beat big-box prices. Listeners: Contact your reps to push PBM changes before independents vanish.   Unfiltered insights on accountability, street safety, and small-business survival—straight talk from two Mississippi originals.

In this special episode of The Real Stuff, I recorded my very first LIVE podcast taping and used it as an opportunity to get honest about wellness, what actually matters, and the moment my body forced me to slow down.Lately, I've been thinking a lot about how wellness culture has become overly complicated. We're obsessing over tiny optimizations and trendy hacks while completely ignoring the foundational habits that actually impact how we feel. In this episode, I talk about why I believe real wellness needs to go back to the basics: getting enough sleep, eating real food, and moving your body (all while, of course, taking care of your mental health).I also share how my relationship with sleep has completely changed over the years—from barely needing it as a teenager to treating it as one of the most sacred parts of my day as an adult. And then I open up about something I haven't shared on the podcast before: a terrifying night terror that escalated into a physical injury and became a major wake-up call for me.I walk you through exactly what happened to me, how stress and hustle culture played a role, and the changes I've made since to protect my nervous system, my sleep, and my overall health. This episode isn't about perfection or wellness trends — it's about listening to your body before it has to scream at you.If you've been feeling burnt out, overwhelmed, or like you're constantly chasing “better” but still feeling exhausted, I hope this conversation helps you zoom out, reset, and focus on what actually supports your well-being. Thank you to Bayer for partnering with us on this episode. If you're ready to get real about your wellness this year, check out Bayer's trusted lineup of products available at Walmart, CVS, Amazon, and Walgreens. Use as directed.Subscribe to Eric Villanueva's substack, Syllabus Health: https://syllabushealth.substack.comWatch this episode in video form on YouTube: https://www.youtube.com/playlist?list=PLjmevEcbh5h5FEX0pazPEtN86t7eb2OgX To apply to be a guest on the show, visit luciefink.com/apply and send us your story. I also want to extend a special thank you to East Love for the show's theme song, Rolling Stone. Follow the show on Instagram: https://www.instagram.com/therealstuffpod Find Lucie here: Instagram: https://www.instagram.com/luciebfink/ TikTok: https://www.tiktok.com/@luciebfink YouTube: https://www.youtube.com/luciebfinkWebsite: https://luciefink.com/ Subscribe to my free newsletter "The Lucie List" here: https://thelucielist.beehiiv.com/subscribeSubscribe to "The Creator Confidential": http://www.luciefink.com/confidentialExecutive Producer: Cloud10Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

1.28.2026 #RolandMartinUnfiltered: FBI Probes Georgia Election Office. GOP Cuts HBCU Voting. Judge Blocks Va. Map. AOC Takes on CVS. The FBI has searched a Georgia election office for evidence to support former President Trump's false claims that his 2020 election defeat was due to widespread voting fraud. In North Carolina, Republicans have reduced the number of voting sites at the nation's largest historically Black college and university, prompting students to file a lawsuit. In Virginia, a judge has blocked lawmakers' pro-Democratic voting map. We'll also bring you the results of a new poll revealing what issues matter most to Virginians. It seems that local and state police agencies are on a collision course with ICE agents. The President of the National Organization of Black Law Enforcement Executives will explain the complexities of this power struggle. New York Congresswoman Alexandria Ocasio-Cortez has called out CVS Health's corporate strategy to monopolize patient care. And a white city councilman in Florida is facing backlash for how he addressed white supremacy. Many people focused on his choice of words in the example and overlooked his core message, prompting calls for his resignation. Download the Black Star Network app at http://www.blackstarnetwork.com! We're on iOS, AppleTV, Android, AndroidTV, Roku, FireTV, XBox and SamsungTV. The #BlackStarNetwork is a news reporting platform covered under Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research.See omnystudio.com/listener for privacy information.

Brianna Bitton was calling out of work because of her period, and lying about why. Doctors told her to "deal with it." So she and her brother Bobby maxed out every credit card they had to create the first PMS gummy vitamin. Two years and 20+ manufacturer rejections later, they launched FLO. Now O Positiv does $275 million in annual revenue; sits in Target, Walmart, and CVS; and is approaching a rumored billion-dollar valuation.  In this episode, they discuss the COVID-era product that tanked, fighting Meta to say the word "vagina," the most telling question they ask when hiring, and why slow and steady (while bootstrapping) won the race.  Key Takeaways and Topics Turning debilitating PMS into a viable business idea Two years of failed R&D and what it taught them about perseverance Bootstrapping with credit cards and managing financial risk Why an immunity product failed and the lesson that reshaped the company Building a women's health category through education Getting banned from Meta ads and changing the policy Product efficacy vs. trend-driven growth Choosing profitability and control over constant fundraising The top question they ask when hiring  Why retention matters more than hype   Links The Failure Factor Podcast was brought to you by Off The Field Coaching. Explore working with one of our coaches at http://offthefieldcoaching.com   Hosted by Megan Bruneau: therapist, executive coach, speaker, Forbes contributor, and host of The Failure Factor. For more info, visit https://meganbruneau.com    Follow O Positiv Instagram: https://www.instagram.com/opositiv Tiktok: https://www.tiktok.com/@opositiv  https://opositiv.com Follow Megan Instagram: https://www.instagram.com/meganjbruneau/ LinkedIn: https://www.linkedin.com/in/megan-j-bruneau-m-a-rcc Subscribe to the podcast newsletter at https://thefailurefactorpodcast.com    

Hey yall! In this episode of the Stella Rae Podcast, I'm sitting down with Scarlett Leung, the co-founder of Pretty Tasty Tea, the viral collagen iced tea brand now in CVS, Target, Sprouts, and thousands of stores nationwide.Scarlett shares her real story of going from Deloitte and corporate fashion to launching startups in fertility, wellness, and now functional beverages. We talk about burnout, career pivots, Eastern medicine, food as medicine, and how she learned to build a business without sacrificing her health or happiness.If you're feeling stuck in your career, burned out, or craving a more aligned version of success, this episode will change the way you think about work, wellness, and what it actually means to “make it.”We also get into how Scarlett plans her year based on how she wants to feel, why she believes in leaving space for rest, and how she built a life and business that actually supports her nervous system.This is for the girlies who want to grow, glow up, and still protect their peace.Enjoy & dont forget to tweet/ig story me a screenshot of you listening!Connect with Scarlett & Pretty Tasty Tea:https://www.prettytasty.com/https://www.instagram.com/drinkprettytasty/https://www.linkedin.com/in/scarlett-leung/I edit using Riverside! https://www.riverside.fm/?utm_campaign=campaign_5&utm_medium=affiliate&utm_source=rewardful&via=stella-holtFollow me!instagram http://instagram.com/stellaraepodcastlisten to and/or support the podcast: https://anchor.fm/stella-raetiktok: http://tiktok.com/@stellaraeherselftwitter: http://twitter.com/stellaraegoodreads: https://www.goodreads.com/user/show/10449999-stella-raemy fav books/products/health: https://www.amazon.com/shop/stellaraemy current filming set up:camera: https://amzn.to/4cEQiLOmicrophone: https://amzn.to/3Z2A5gctripod: https://amzn.to/3AEmxgKring light: https://amzn.to/3XxZrShbox lights: https://amzn.to/4e1Q1Ubportable light for phone: https://amzn.to/3XxZspjjoin my patreon for ad-free episodes, early access, merch discounts, behind the scenes, & more! https://www.patreon.com/stellaraepodlisten on spotify: https://open.spotify.com/show/2DMbeh7EqiqgROIjvW0sI9listen on apple podcasts: https://podcasts.apple.com/us/podcast/the-stella-rae-podcast/id125561818200:00 – scarlett introduces pretty tasty tea01:05 – how collagen and chinese medicine inspired her brand02:45 – from deloitte to fashion to startups03:30 – being recruited to start an egg freezing company05:10 – why being a generalist made her a better founder06:30 – growing up with eastern medicine and food as medicine08:20 – winter wellness tips and immune support10:15 – dealing with self doubt as a ceo11:40 – setting goals based on how you want to feel13:10 – her yearly reflection and planning system14:40 – manifestation, alignment, and intuition16:30 – building a career that includes fun and creativity17:50 – how to find work that fits your values19:10 – why it's never too late to change careers20:10 – networking and building a diverse friend group22:20 – trying new paths without quitting everything23:30 – chef school, burnout, and funny career detours25:20 – creating a healthier work culture as a ceo27:00 – how she schedules rest and avoids burnout29:10 – planning workouts and protecting personal time30:40 – overstimulation, introversion, and needing alone time31:30 – astrology, scorpio energy, and 2026 vibes33:00 – her advice for burnout and career pivots35:00 – taking leaps of faith36:10 – where to find pretty tasty tea and scarlett#StellaRaePodcast

January 27, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: P&G acquires Wonderbelly, the digestive wellness brand with distribution at CVS and Target, moving to reposition digestive health as wellness  Once Upon a Farm kicks off IPO roadshow targeting $200M+ raise at $760M valuation, testing whether premium mission-driven food brands can sustain consumer trust and growth Life Time reports preliminary Q4 & FY25 earnings, with revenue up 14% as revenue per member jumps double digits, planning to open 12-14 large-format clubs in 2026 New racket sport Typti launches with backing from 80+ athletes including Drew Brees, targeting tennis players on pickleball courts as participation sports spawn new ecosystems More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co  

Hello to our lovely coven, happy Friday! Today we get knee deep in all of your crazy Heauxmetown Hero tales, and dive into the nitty gritty for WWDD.  In need of something cute and cozy for the winter? Get yourself or whoever's on your daddy list a beanie, hoodie, or daddy hat from our store! Please support our show and show off your love for Disrespectfully by repping our official gear :) K Love ya bye! Thank you to our sponsors! Hungryroot: Go to https://Hungryroot.com/disrespectfully and use code DISRESPECTFULLY to get 40% off your first box and a free item of your choice for life. Revolve: Head to https://Revolve.com/disrespectfully for 15% off your first order with code: DISRESPECTFULLY.  Offer ends February 6th. Rocket Money: Let Rocket Money help you reach your financial goals faster. Join at https://Rocketmoney.com/disrespectfully  Beekeeper's Naturals: https://Beekeepersnaturals.com/disrespectfully to get 20% off your order. Also available at Target, Whole Foods, Walmart, Amazon, CVS, and Walgreens. Perelel: Visit https://Perelelhealth.com to enjoy 20% off their first order with code: DISRESPECTFULLY Need Advice? We are here to help! Send your questions to disrespectfullypod@gmail.com and we may answer your questions on the show! Connect with the Coven! Facebook: https://www.facebook.com/groups/1930451457469874 Reddit: https://www.reddit.com/r/disrespectfullypod/ Listen to us on Apple: https://podcasts.apple.com/us/podcast/disrespectfully/id1516710301 Listen to us on Spotify: https://open.spotify.com/show/0J6DW1KeDX6SpoVEuQpl7z?si=c35995a56b8d4038 Follow us on Social! Disrespectfully Instagram: https://www.instagram.com/disrespectfullypod Disrespectfully Tiktok: https://www.tiktok.com/@disrespectfullypod Katie Maloney Instagram: https://www.instagram.com/musickillskate Dayna Kathan Instagram: https://www.instagram.com/daynakathan Leah Glouberman Instagram: https://www.instagram.com/leahgsilberstein Allison Klemes Instagram: https://www.instagram.com/allisonklemes/ Cassie Galonsky Instagram: https://www.instagram.com/cassieg2011/  Buy our merch!  https://disrespectfullypod.com/ Disrespectfully is an Envy Media Production.

Five health insurance CEOs faced a historic grilling on Capitol Hill this week, and the fallout affects every healthcare provider in America.In this episode, Conrad Meyer and Rory Bellina break down the January 2026 congressional hearings where lawmakers from both parties hammered executives from UnitedHealth, CVS, Cigna, Elevance, and Ascendiun over skyrocketing premiums, claim denials, and the use of AI to reject patient care.We cover:→ Why premiums are doubling after the ACA subsidy expiration→ The new Medicare AI pilot program (WISeR) and what it means for your practice→ How AI-driven prior authorization is linked to denial rates 16x higher than human review→ New state laws in Texas and California requiring AI disclosure→ What Louisiana providers need to know right now→ Six practical steps to protect your patients and your practiceWhether you're a physician, hospital administrator, compliance officer, or healthcare attorney, this episode gives you the legal context and actionable takeaways you need.This podcast is for educational purposes only and does not constitute legal advice.Contact: 504-833-5600 | chehardy.com#HealthLaw #PriorAuthorization #HealthcareAI #PhysicianAdvocacy #HealthcareCompliance #Louisiana

On our first show of the week, Lynette faces down a nearly empty house, Stefanie takes you on a journey aimed at filling hers and a quick update about Xander's college applications. Plus, CVS is annoying.Become a Fora advisor today at ForaTravel.com/FCOLGet 10% off your order at Hero.co and use code FCOLFor them GLP-1s go to ForHers.com/Crying

Women comprise 75% of the healthcare workforce and make the majority of family healthcare decisions—yet hold only 20% of senior leadership positions. Dr. Amy Compton-Phillips, Executive Vice President and Chief Medical Officer of CVS Health, sees this gap as more than unfair. At CVS Health, Dr. Amy oversees clinical strategy for 9,000 community access points with a clear mission: simplify healthcare and make the right thing the easy thing. "We've put things like electronic medical records, narrow insurance networks, and administrative rigmarole between patients and people who can help them," she explains. "How can we start taking layers out?" But she didn't reach this role by following the traditional playbook. She turned down her dream job because the timing wasn't right for her family. She went part-time during peak career years, trading off with her husband as their priorities shifted. And she's consistently been tapped on the shoulder for opportunities rather than raising her hand, which taught her that doing your current job exceptionally well matters more than constantly positioning for the next one. In this conversation, Dr. Amy explains why healthcare needs women's voices at the executive table for design thinking that actually works, how she and her husband negotiated dual careers through different life stages, why "performance gets you the podium" but authenticity and strategic thinking get you the C-suite, and what it takes to be heard when you're the only woman in leadership rooms. Whether you're balancing clinical practice with administrative responsibilities, navigating when to say yes and no to opportunities, or building toward senior healthcare leadership, this is uncommon honesty about the trade-offs and strategies that actually matter. Key Takeaways: Do your current job exceptionally well—performance gets you noticed before you ever raise your hand Design healthcare systems with women's voices at the table; they're both the workforce majority and primary family decision-makers Negotiate career trade-offs with your partner over time; one person doesn't have to sacrifice permanently Saying no to your dream job might be the smartest move you make—if they value you, they'll come back Taking layers out of complexity requires intentional design thinking, not just adding more solutions Figure out what's working and what's not, then adjust your strategy—sometimes you need to literally or metaphorically elevate yourself to be heard About the Guest: Dr. Amy Compton-Phillips is Executive Vice President and Chief Medical Officer of CVS Health, where she leads clinical strategy across 9,000 community locations. She previously served as President and Chief Clinical Officer at Providence, a $25 billion health system with 52 hospitals and 120,000 caregivers, where she led the response to the first confirmed COVID-19 case in the United States. Earlier, she spent 22 years at Kaiser Permanente, rising from front-line internist to Chief Quality Officer. A CNN Medical Analyst and keynote speaker, she has served on boards including HIMSS, the Institute for Systems Biology, and Wellcare. She holds her bachelor's degree from Johns Hopkins University and her medical degree from the University of Maryland School of Medicine. Health Podcast Network Chapters 00:00 - Introduction and Holiday Health Tips 02:38 - Simplifying Health at CVS 05:31 - The Voice of the Customer: Women in Leadership 08:42 - Career Progression: Being Tapped on the Shoulder 10:11 - Saying No to the Dream Job 12:39 - Making Choices: Work-Life Integration 15:05 - Going Part-Time and Life Partner Negotiation 17:55 - Pull Out the Platform Shoes: Getting Heard as a Leader Guest & Host Links Connect with Laurie McGraw on LinkedIn Connect with Dr. Amy Compton-Phillips on LinkedIn Connect with Inspiring Women Browse Episodes | LinkedIn | Instagram | Apple | Spotify

This week, Cy goes to Walgreens or CVS and Chad celebrates Christmas again. Sign up for Chad's ⁠texting list here!⁠ Or, text the word CHAD to 208-379-6947! Sign up for Cy's ⁠texting list here! Or⁠, text the word SHOW to 202-771-5171! This episode is brought to you by Shopify! --- Follow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Chad Daniels (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@ThatChadDaniels⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) is a Dad, Comedian, and pancake lover. With over 750 million streams of his 5 albums to date, his audio plays are in the 99th percentile in comedy and music on Pandora alone, averaging over 1MM per week. Chad's previous album, Footprints on the Moon was the most streamed comedy album of 2017, and he has 6 late-night appearances and a Comedy Central Half Hour under his belt. Cy Amundson (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@CyAmundson⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) With appearances on Conan, Adam Devine's House Party, and Comedy Central's This is Not Happening, Cy Amundson is fast-proving himself in the world of standup comedy. After cutting his teeth at Acme Comedy Company in Minneapolis, has since appeared on Family Guy and American Dad and as a host on ESPN's SportsCenter on Snapchat. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this Omni Talk Retail episode, recorded live from NRF 2026, Mike Wier, Vice President of Store Brands at CVS, joins Anne Mezzenga and Chris Walton to discuss how CVS is rethinking private brands as a core growth engine across health, wellness, and everyday convenience. Mike explains what it means to run store brands like a “mini CEO,” overseeing product development, sourcing, branding, and growth across a 9,000-store footprint. With most CVS customers shopping quick, mission-driven trips, the conversation focuses on how simplicity, clarity, and trust at the shelf are shaping CVS's private brand strategy. Looking ahead, Mike outlines his vision for CVS private brands evolving beyond the store, becoming trusted consumer brands that extend outside of CVS's four walls and operate more like modern CPG companies. Key Topics Covered: -What it means to lead private brands as a “mini CEO” inside CVS -Why CVS simplified dozens of brands into a focused brand portfolio How short, mission-driven trips shape private brand strategy -Repositioning the CVS brand for health, wellness, and trust -Packaging simplification and shelf clarity as competitive advantages -Competing with national brands in wellness and everyday essentials -Why CVS private brands may expand beyond CVS stores -How private brands are becoming long-term growth platforms Thank you to Vusion for supporting Omni Talk Retail's NRF 2026 coverage, and thank you to our listeners for following along throughout the show. #NRF2026 #CVS #PrivateBrands #StoreBrands #RetailStrategy #HealthAndWellness #RetailBranding #RetailInnovation #OmniTalkRetail

Meghan Trainor is back on the show this week!! Drew and Meghan talk about what it's like going on tour with your family, hearing your songs blasting at CVS, Meghan's childhood football era, Drew cutting off her widow's peak as a kid, how Chloë Grace Moretz is responsible for Meghan meeting her husband Daryl, and so much more. Meghan IG: https://www.instagram.com/meghantrainor/?hl=enMeghan Tiktok: https://www.tiktok.com/@meghantrainor?lang=en Follow The Comment Section on IG: https://www.instagram.com/thecommentsection/?hl=en Learn more about your ad choices. Visit podcastchoices.com/adchoices

Eliot has beef with the CVS coupon system. Then, it's Joseph's lucky day, because we're comparing car lengths, and you'll never guess who's is longest!If you'd like a second full episode every week, plus video of every episode and monthly bonuses, head over to nevernotfunny.com and sign up for a Platinum subscription. Plans start at $6/month and more perks, like access to our back catalog and game nights on Zoom, are also available. Sign up today!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.